Introduction {#s1}
============

Cytokinesis is the physical division of one cell into two daughter cells, which occurs at the end of the cell cycle. In animal cells, cytokinesis is driven by the equatorial constriction of an actomyosin contractile ring, composed of diaphanous family formin-nucleated F-actin and the motor myosin-II (for review see \[[@bib21]; [@bib23]; [@bib46]; [@bib72]; [@bib77]; [@bib86]\]). Cytokinesis failure, which results in a binucleate tetraploid (polyploid) cell, can lead to human diseases including blood syndromes, neurological disorders, and cancer ([@bib9]; [@bib81]; [@bib30]; [@bib116]; [@bib65]; [@bib54]; [@bib69]; [@bib33]; [@bib37], [@bib38]; [@bib114]). While it has long been assumed that all animal cells divide by a similar molecular mechanism, it is becoming increasingly clear that the functional regulation of cytokinesis has more diversity, or variation in mechanistic and regulatory pathways, than previously appreciated ([@bib52]; [@bib47]; [@bib35]; [@bib51]; [@bib27]; [@bib22]; [@bib119]; [@bib104]). In many animals (including humans), specific cell types or cell lineages within the organism are programmed to fail in cytokinesis and become bi- or multi-nucleate (e.g. osteoclasts in bone, megakaryocytes in blood, cardiomyocytes in the heart, hepatocytes in the liver) ([@bib65]; [@bib114]; [@bib123]; [@bib32]; [@bib108]). Thus, in some cell types, cytokinesis failure occurs normally during development and/or homeostasis and, in other cell types, cytokinesis failure can be pathogenic ([@bib65]; [@bib114]; [@bib123]; [@bib32]; [@bib108]), indicating a high degree of cellular variation in both the regulation of cytokinesis and the consequences of cytokinesis failure.

As further support for cell-type-specific cytokinetic variation, genomic analysis has revealed that organism-wide mutations in cytokinesis genes are associated with cell-type-specific disruption of cell division in flies, fish, worms, rodents, and even humans ([@bib9]; [@bib81]; [@bib116]; [@bib69]; [@bib99]; [@bib110]; [@bib82]; [@bib39]; [@bib84]; [@bib75]; [@bib78]; [@bib55]; [@bib28]; [@bib71]; [@bib1]). In human patients, genome-wide association studies have revealed that genomic mutations in cytokinesis genes lead to cell-type-specific division failure and cell- or tissue-type-specific pathologies. For example, an autosomal dominant mutation in the human kinesin-6 MKLP1, a protein thought to be essential for cytokinesis in all animal cells ([@bib40]), leads to congenital dyserythropoietic anemia type III ([@bib69]). These patients have multinucleated erythroblasts due to a failure in cytokinesis but are otherwise asymptomatic, indicating that cells in other tissues and organs divide successfully ([@bib69]). Mutations in Citron Kinase are associated with cytokinesis failure specifically in neuronal precursor cells, leading to multinucleated neurons and microcephaly in mice, rats, and human patients, but the development of other tissues and organs is not grossly disrupted ([@bib99]; [@bib28]; [@bib1]; [@bib48]; [@bib68]; [@bib6]; [@bib100]). Moreover, a mouse knockout of the microtubule and actin-binding protein GAS2L3 dies shortly after birth due to specific defects in cardiomyocyte cytokinesis during heart development, but the overall development of other tissues is not affected ([@bib104]). These findings suggest that cell-type-specific mechanisms modulate the diversity of cytokinesis in animal cells, but the cellular and molecular mechanisms that underlie this diversity are poorly understood, even at a basic level.

There are two fundamental cell-type-specific regulatory mechanisms that could underlie cytokinetic variation: cell-intrinsic regulation (e.g. cell polarity, inherited proteins and RNAs) and cell-extrinsic regulation (e.g. cell-fate signaling, cell-cell adhesions). There is some evidence in support of each model. In support of cell-intrinsic regulation, we and others found that cell polarity proteins can promote robust cytokinesis during asymmetric cell division ([@bib56]; [@bib17]; [@bib94]), and asymmetrically inherited RNA granules in germ lineage cells contain a key splicing regulator involved in cytokinesis ([@bib4]). In support of extrinsic regulation, cell-cell adhesion junctions have been implicated in regulating contractile ring constriction in epithelial cells ([@bib47]; [@bib35]; [@bib51]; [@bib11]; [@bib85]; [@bib66]; [@bib117]; [@bib24]), and cell-fate signaling molecules, such as Wnt and Src, have been linked to cytokinesis in some contexts ([@bib36]; [@bib60]; [@bib102]). Thus, both cell-intrinsic and -extrinsic regulatory mechanisms could contribute to cel- type-specific diversity in cytokinesis.

The *C. elegans* four-cell embryo is a powerful, optically clear system to probe the mechanisms of cell-type-specific variation in cytokinesis. All four-cell divisions occur within a \~20 min time frame, and cytokinesis can easily be monitored in each individual blastomere, or cell within the embryo, by light microscopy. Worm development follows a defined cell lineage pattern ([@bib106]; [@bib107]), and the cell-fate patterning of each blastomere in the four-cell embryo is known ([@bib93]). At the four-to-eight-cell division, each of the four cells are already specified to form distinct cell linages by conserved, well-characterized cell-fate signaling pathways (e.g. Notch/Delta, Wnt, Src; for review see \[[@bib93]; [@bib87]; [@bib14]\]). The two-cell embryo divides to form two anterior blastomeres, ABa and ABp, and two posterior blastomeres, EMS and P2. While the anterior blastomeres are born as identical sisters, activation of Notch family receptors in ABp by a Delta-like ligand on the surface of P2 induces ABp to adopt a different cell fate than ABa ([@bib76]; [@bib13]; [@bib74]; [@bib80]; [@bib101]). The two posterior blastomeres, EMS and P2, are born from an asymmetric cell division and cell-cell contact-mediated Wnt and Src signaling between P2 and EMS promote asymmetric cell division and cell fate specification in both cells ([@bib41], [@bib42], [@bib43], [@bib44]; [@bib91]; [@bib111]; [@bib7]; [@bib3]; [@bib96]). Therefore, in the four-cell *C. elegans* embryo, each cell has a unique cell identity and can be individually scored for contractile ring constriction during cytokinesis.

To study the mechanisms of cytokinetic variation, we combined thermogenetics with cell type-specific in vivo and ex vivo analysis of cytokinesis in each blastomere of the four-cell *C. elegans* embryo. We used fast-acting temperature-sensitive (ts) alleles to inactivate two cytokinesis proteins essential for contractile ring constriction in the one-cell embryo ([@bib25]; [@bib70]): the motor myosin-II (NMY-2 in *C. elegans*, hereafter myosin-II^NMY-2^) and the diaphanous formin CYK-1 (hereafter formin^CYK-1^). We identified cell-type-specific variation in four-cell embryos in the molecular requirement for formin^CYK-1^, but not myosin-II^NMY-2^. Specifically, we found that while cytokinesis in two blastomeres, ABa and ABp, is sensitive to reduced formin^CYK-1^ activity, cytokinesis in the other two blastomeres, EMS and P2, is resistant to defects in formin^CYK-1^-mediated F-actin assembly. Likewise, cytokinesis in ABa and ABp cells is sensitive to treatment with low doses of LatrunculinA (LatA), a drug that block F-actin polymerization, whereas cytokinesis in EMS and P2 cells is resistant to LatA. We further found that EMS and P2 cells have greatly reduced F-actin levels at the division plane upon formin^CYK-1^ disruption, despite considerable and often successful equatorial constriction during cytokinesis, suggesting that cytokinesis in these cells is less dependent on F-actin in the contractile ring. To determine if EMS- and P2-specific variation in cytokinesis regulation is due to cell-intrinsic or -extrinsic regulation, we isolated individual blastomeres by embryo microdissection and examined the effect on cytokinesis when kept in isolation or when sister blastomeres were paired. We found that P2 cells are protected against cytokinesis failure after formin^CYK-1^ disruption even when isolated from the embryo, indicating cell-intrinsic regulation of cytokinesis, whereas EMS cells are not protected against cytokinesis failure upon isolation. EMS cytokinetic protection is restored upon pairing with P2, but not with ABa/ABp cells, indicating that cytokinesis in EMS is subject to cell-extrinsic regulation by P2. Finally, we found that cytokinesis in EMS is dependent on the proto-oncogenic tyrosine kinase Src^SRC-1^, a critical player in EMS cell fate specification that is known to be activated in EMS by direct contact with P2 ([@bib7]; [@bib3]). This work establishes the *C. elegans* four-cell embryo as a system to study cytokinetic variation and demonstrates that both cell-intrinsic and -extrinsic regulations contribute to cell-type-specific diversity in cytokinetic mechanisms.

Results {#s2}
=======

We first sought to identify variation in the regulation of cytokinesis in individual blastomeres within the four-cell *C. elegans* embryo ([Figure 1A](#fig1){ref-type="fig"}). To do this, we took a thermogenetic approach and used fast-acting ts alleles to weaken the contractile ring, while monitoring differences in cytokinesis between ABa, ABp, EMS, and P2 at increasing temperatures by spinning disc confocal microscopy. We used ts alleles of two contractile ring proteins known to be essential for cell division in most animal cell types ([@bib25]; [@bib70]; [@bib98]; [@bib19]; [@bib2]; [@bib10]; [@bib79]; [@bib20]; [@bib61]): the motor myosin-II^NMY-2^ (*nmy-2(ne3409ts)*, hereafter *myosin-II^nmy-2^(ts)*) and the diaphanous formin^CYK-1^ (*cyk-1(or596ts)*, hereafter *formin^cyk-1^(ts)*). The *myosin-II^nmy-2^(ts)* mutant has a point mutation in the myosin neck (S2) domain, required for dimerization and head coupling ([@bib70]; [@bib109]). The *formin^cyk-1^(ts)* mutant has a point mutation in the post-region (FH2 domain) required for dimerization and processive F-actin polymerization ([@bib88]), including at the division plane ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) ([@bib25]). Both mutations completely block cytokinesis in the *C. elegans* one-cell embryo and have a null-like phenotype at restrictive temperature (26°C), with no contractile ring constriction ([@bib25]).

![Cytokinetic variation with loss of formin^CYK-1^, but not myosin-II^NMY-2^, activity in individual blastomeres of the four-cell embryo.\
(**A**) Lineage map showing the identity and division patterning that occurs during the early blastomere divisions in the *C. elegans* embryo. Founder cells AB, E, MS, C, D, and P4 are indicated in dark blue. (**B**) Schematic of the experimental protocol for the thermal sensitivity assay. Individual ts mutant (or control) four-cell embryos were upshifted from permissive temperature (16°C) to a higher temperature across a thermal range (18--26°C) prior to anaphase onset in each blastomere. (**C**) Graphs showing the cytokinetic outcome for control*, myosin-II^nmy-2^(ts)*, and *formin^cyk-1^(ts)* mutant embryos upshifted to specific temperatures prior to anaphase onset. AO = anaphase onset. The percent of cells exhibiting each cytokinetic phenotype at the indicated temperature is plotted for each cell type and genotype. n ≥ 81 for each cell type (detailed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}).](elife-36204-fig1){#fig1}

These ts mutants are functionally tunable with temperature, having higher activity at lower temperatures and lower activity at higher temperatures ([@bib26]). We used this property of thermal tunability to determine if the requirement for myosin-II^NMY-2^ or formin^CYK-1^ varies between the four different blastomeres. We upshifted ts mutant four-cell embryos from a permissive temperature (16°C) to a higher temperature across a thermal range up to restrictive temperature (18--26°C) before anaphase onset and monitored the cytokinetic phenotype at that temperature ([Figure 1B](#fig1){ref-type="fig"}, [Video 1](#video1){ref-type="video"} and see Materials and methods). In control embryos, all four blastomeres successfully completed cytokinesis after pre-anaphase upshift across the range of temperatures tested ([Figure 1B,C](#fig1){ref-type="fig"}). In *myosin-II^nmy-2^(ts)* embryos, individual blastomeres within the four-cell embryo exhibited a similar frequency of cytokinesis failure after pre-anaphase upshift to higher temperatures across the range of upshift temperatures tested ([Figure 1B,C](#fig1){ref-type="fig"}), although ABa and ABp failed in cytokinesis at a slightly lower frequency than EMS and P2 at intermediate temperatures (20--22°C; [Figure 1C](#fig1){ref-type="fig"}). Thus, we found that decreased levels of myosin-II^NMY-2^ activity caused a similar frequency of cytokinesis failure in all four blastomeres.

###### Control, *myosin-II^nmy-2^(ts)*, and *formin^cyk-1^(ts)* mutant embryos undergoing cytokinesis at the restrictive temperature.

The three *formin^cyk-1^(ts)* mutant embryos show phenotypic variation in the cytokinesis outcome for EMS and P2, as is observed at this temperature. 60 s per frame; temperature, 26°C. Green, GFP::PH (plasma membrane); magenta, mCherry::histone2B; scale bar = 10 µm.
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In contrast, *formin^cyk-1^(ts)* embryos showed substantial blastomere-specific differences in cytokinesis failure after upshift to increasing temperatures. ABa and ABp cells from *formin^cyk-1^(ts)* embryos were similar to the one-cell embryo ([@bib25]): they started to fail in cytokinesis at 19 and 21°C, respectively, and both blastomeres failed in cytokinesis 100% of the time when upshifted to fully restrictive temperature (26°C; [Figure 1C](#fig1){ref-type="fig"}). In contrast, EMS and P2 cells from *formin^cyk-1^(ts)* embryos were relatively resistant to cytokinesis failure. Both blastomeres successfully completed cytokinesis 100% of the time below \~24°C and with high frequency even at 26°C, a temperature at which ABa and ABp always fail in cytokinesis (5/9 EMS and 4/11 P2 cells, versus 0/5 ABa and 0/5 ABp cells, complete cytokinesis at 26°C; [Figure 1C](#fig1){ref-type="fig"}). In fact, even at 27°C, a temperature at which even control worms start to show developmental defects due to thermal stress, \~40% of pre-anaphase upshifted EMS and P2 cells were still able to divide in *formin^cyk-1^(ts)* embryos (5/12 EMS and 7/17 P2 cells, versus 0/10 ABa and 0/10 ABp cells, complete cytokinesis at 27°C; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Together, these data show that cytokinesis in EMS and P2 requires lower levels of formin^CYK-1^ activity than cytokinesis in ABa and ABp cells (or the one-cell embryo, see \[[@bib25]\]), and suggests that cytokinesis in these cells is differentially regulated at a cell-type-specific level.

To test for differences in the temporal requirements for these contractile ring proteins between the individual blastomeres, we next performed temperature upshifts from permissive (16°C) to fully restrictive (26°C) temperature with *myosin-II^nmy-2^(ts)* and *formin^cyk-1^(ts)* mutant four-cell embryos at specific times before and after anaphase onset and monitored the frequency of cytokinesis failure in ABa, ABp, EMS, and P2 cells ([Figure 2A](#fig2){ref-type="fig"}, see Materials and methods). In control embryos, all four blastomeres successfully completed cytokinesis 100% of the time, irrespective of when the thermal upshifts occurred (n ≥ 57 for each cell type; [Figure 2B](#fig2){ref-type="fig"}). In *myosin-II^nmy-2^(ts)* embryos, all four blastomeres were similar to the one-cell embryo and failed in cytokinesis 100% of the time whether upshifted before anaphase onset or later, up to ≤10 min after anaphase onset (just prior to contractile ring closure) (n ≥ 67 for each cell type; [Figure 2B](#fig2){ref-type="fig"}) ([@bib25]). Thus, we found that myosin-II^NMY-2^ activity is temporally required throughout cytokinesis in all four blastomeres.

![Cytokinetic variation in the temporal requirement for formin^CYK-1^, but not myosin II^NMY-2^, in individual blastomeres of the four-cell embryo.\
(**A**) Schematic of the experimental protocol for the temporal functional requirement assay in which four-cell stage embryos were upshifted from permissive (16°C) to restrictive temperature (26°C) at defined time points relative to anaphase onset in each individual blastomere, then held at 26°C throughout cytokinesis. (**B**) Graphs showing the cytokinetic outcome for control*, myosin-II^nmy-2^(ts)*, and *formin^cyk-1^(ts)* mutant embryos upshifted from 16°C to 26°C at different times during cell division. The cytokinetic outcome of each cell is plotted as a percent of the total number of cells upshifted to 26°C at that time relative to anaphase onset. AO = anaphase onset (magenta dashed line); C = approximate time of contractile ring closure at 16°C (dark blue dashed line); n ≥ 57 for each cell type (see [Supplementary file 1](#supp1){ref-type="supplementary-material"}).](elife-36204-fig2){#fig2}

In contrast, *formin^cyk-1^(ts)* embryos again showed cell type variation in the temporal requirement for activity among individual blastomeres. In our previous analysis of the one-cell *C. elegans* embryo, cytokinesis failed 100% of the time with formin^CYK-1^ inactivation by thermal upshift to restrictive temperature at any time before mid-ring constriction ([@bib25]). Consistent with this, ABa and ABp cells in *formin^cyk-1^(ts)* embryos failed in cytokinesis 100% of the time when upshifted to 26°C prior to anaphase onset (n ≥ 61 for each cell type; [Figure 2B](#fig2){ref-type="fig"}). However, ABa and ABp cells differed in their temporal requirement for formin^CYK-1^ activity when upshifted ≤10 min after anaphase onset: while ABa cells failed in cytokinesis 100% of the time, ABp cells failed only \~50% of the time (n ≥ 61 for each cell type; [Figure 2B](#fig2){ref-type="fig"}). EMS and P2 cells in *formin^cyk-1^(ts)* mutant embryos exhibited even more dramatic differences in cytokinesis failure. A number of these cells successfully divided when upshifted to 26°C well before anaphase onset (14/43 EMS and 16/50 P2 cells complete cytokinesis) ([Figures 2B and C](#fig2){ref-type="fig"}) and showed substantial equatorial constriction and frequent successful cytokinesis when upshifted to 26°C after anaphase onset ([Figure 2B](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Thus, while formin^CYK-1^ activity is essential in ABa and ABp, with ABa requiring high functional levels of formin^CYK-1^ activity throughout the entirety of cytokinesis and ABp requiring formin^CYK-1^ activity only early in contractile ring assembly and constriction (like in the 1 cell embryo, see \[[@bib25]\]), EMS and P2 cells have lower overall requirements for formin^CYK-1^ activity. Taken together, our functional and temporal requirement analysis suggests that differences in formin^CYK-1^-mediated actin dynamics may underlie cell-type-based cytokinetic diversity.

In animal cells, diaphanous family formin-mediated assembly of linear F-actin during cytokinesis is thought to be essential for the assembly and constriction of the actomyosin contractile ring ([@bib23]; [@bib86]; [@bib98]; [@bib10]). Formin^CYK-1^ is the only worm diaphanous family formin ([@bib89]). In *formin^cyk-1^(ts)* mutant one-cell *C. elegans* embryos at 16°C, F-actin is present in the contractile ring (although at lower levels than in control embryos) but, upon upshift to 26°C, linear F-actin is no longer visible and cytokinesis fails ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and \[[@bib25]\]). It is possible that in EMS and/or P2, another formin-related protein could function redundantly with formin^CYK-1^ to ensure F-actin assembly during cytokinesis in these specific cells. Transcriptional analysis has revealed there are two other formin-related genes (*inft-2* and *frl-1)* expressed at the four-cell stage ([@bib49]), but no formin-related gene is significantly over-expressed in either EMS or P2, relative to in ABa or ABp ([@bib113]). To test if other formin-related proteins could compensate for loss of formin^CYK-1^ activity during cytokinesis in EMS and P2, we depleted the six other *C. elegans* formin-related proteins by RNAi in *formin^cyk-1^(ts)* mutants and monitored the success or failure of cytokinesis in the four-cell embryo. If another formin-related protein compensates for a loss of formin^CYK-1^ activity, then reducing the levels of that formin should increase the frequency of cytokinesis failure in EMS and P2. Instead, we found that individual depletion of the other formin-related proteins did not decrease the frequency cytokinesis failure in any of the four blastomeres in *formin^cyk-1^(ts)* mutants ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). This suggests that no single formin-related protein is compensating for loss of formin^CYK-1^ activity, although we cannot rule out that multiple formin-related proteins may function together during cytokinesis in EMS and P2 specifically.

Although *formin^cyk-1^* mRNA levels do not vary across the four blastomeres ([@bib113]), it is possible that formin^CYK-1^ protein levels are higher in EMS and/or P2, thus leading to higher formin^CYK-1^ activity and higher resistance to partial inactivation of formin^CYK-1^ function in these cells. To test this possibility, we tagged the C-terminus of formin^CYK-1^ at the endogenous locus using a CRISPR/Cas9 method ([@bib29]) and generated a homozygous *C. elegans* strain expressing formin^CYK-1^::eGFP ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Using this strain, we imaged the four cell types after formation and partial ingression of the contractile ring in each cell type and found that formin^CYK-1^::eGFP localized nearly exclusively to the division plane during cytokinesis in all four blastomeres. Analysis of the maximum intensity projection (which captures the cortical eGFP signal) revealed that formin^CYK-1^::eGFP is present at similar peak levels at the division plane in all four cells ([Figure 3](#fig3){ref-type="fig"}). Sum intensity projection analysis (total levels) revealed that formin^CYK-1^::eGFP is reduced in EMS and P2, versus ABa/ABp blastomeres ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). While the challenges of sum intensity projection analysis in multicellular embryos make it difficult to form conclusions about protein levels using this approach (see Materials and methods for additional information), these results are consistent with the maximum intensity projection analysis and do not support the hypothesis that resistance to formin^CYK-1^ inactivation in EMS and P2 is due to an endogenous enrichment of formin^CYK-1^ protein in these cells relative to ABa and ABp at the four-cell stage.

![Formin^CYK-1^ localizes to the contractile ring at similar peak levels in the ABa, ABp, EMS and P2 cells.\
(**A**) Representative maximum intensity projection images showing formin^CYK-1^::GFP localization at the division plane in ABa and ABp (left panel), EMS (center panel), and P2 (right panel). Images were acquired after observation of the onset of contractile ring constriction (initial furrowing). (**B**) Schematic showing how formin^CYK-1^::GFP levels were measured along a line scan across the division plane. (**C**) Graph showing all four cells show a local peak in the level of formin^CYK-1^::GFP at the division plane. (**D**) Schematic showing how formin^CYK-1^::GFP levels at the division plane were measured. (**E**) Graph showing the average fluorescence maximum intensity of formin^CYK-1^::GFP at the contractile ring is not significantly different between ABa, ABp, EMS, or P2. Two-tailed t-test ([Supplementary file 1](#supp1){ref-type="supplementary-material"}); n.s., no significance, p\>0.05. Error bars, mean ± SEM; temperature, 21°C; scale bar = 10 µm.](elife-36204-fig3){#fig3}

If multiple formin-related proteins function together to promote contractile ring assembly in EMS and P2 when formin^CYK-1^ activity is reduced, then F-actin at the division plane should remain at high levels in these cells upon temperature upshift in *formin^cyk-1^(ts)* mutant embryos. This outcome would also be predicted if stable, pre-existing F-actin filaments, rather than de novo formin^CYK-1^-nucleated filaments, comprise the contractile ring during cytokinesis in EMS and P2. Thus, we next measured contractile ring F-actin levels in *formin^cyk-1^(ts)* mutant embryos after the onset of equatorial constriction at the four-cell stage using the F-actin reporters Lifeact::RFP, PLST-1::GFP, and GFP::Utrophin^ABD^ ([@bib56]; [@bib90]; [@bib16]; [@bib31]; [@bib115]) to label the entire F-actin cytoskeleton including the contractile ring ([Figure 4](#fig4){ref-type="fig"}; [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}). F-actin was enriched at cell-cell junctions and at the cell division plane in all four blastomeres in control embryos at both 16°C and 26°C and in *formin^cyk-1^(ts)* embryos at permissive temperature, 16°C ([Figure 4](#fig4){ref-type="fig"}; [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}). In *formin^cyk-1^(ts)* embryos at restrictive temperature (26°C), F-actin was still present at the cell-cell junctions but was not enriched at the contractile ring during cell division in any of the four blastomeres, including in EMS and P2 cells that successfully completed cytokinesis ([Figure 4](#fig4){ref-type="fig"}; [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}). It is important to note that these *C. elegans* F-actin reporters are dim, even in control embryos; thus, our inability to detect F-actin on our microscope system with these reporters does not indicate an absence of F-actin in the contractile ring. Nonetheless, together with our formin-related protein RNAi mini-screen results ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), the decrease in robust F-actin levels in all cells in *formin^cyk-1^(ts)* embryos at restrictive temperature suggests that equatorial constriction and successful cytokinesis in EMS and P2 is not likely due to F-actin assembly by another formin-related protein or due to utilization of pre-existing stabilized F-actin to form the contractile ring. Instead, it suggests cell-type-specific mechanism(s) allow cytokinesis to occur in the absence of a robust F-actin cytoskeleton in these blastomeres.

![EMS and P2 cells can divide in the absence of a robust F-actin contractile ring.\
(**A**) Representative images showing Lifeact::RFP-labeled contractile ring F-actin can be seen in EMS and P2 cells in control embryos at 16 and 26°C and in *formin^cyk-1^(ts)* embryos at 16°C, but not in *formin^cyk-1^(ts)* embryos at 26°C. Arrowheads (magenta) indicate the division plane/site of initial furrowing. (**B**) Schematic showing how F-actin levels were measured along a line scan across the division plane in EMS and P2 cells. Images were acquired after observation of the onset of contractile ring constriction (initial furrowing). (**C**) Graphs showing line scans across EMS and P2 cells have a local peak in Lifeact::RFP-labeled F-actin at the division plane in control embryos at 16 and 26°C and *formin^cyk-1^(ts)* embryos at 16°C, but not in *formin^cyk-1^(ts)* embryos at 26°C. (**D**) Schematic showing how F-actin levels at the division plane were measured in EMS and P2 cells. Images were acquired after observation of the onset of contractile ring constriction (initial furrowing). (**E**) Graphs showing the average fluorescence intensity of Lifeact::RFP at the division plane in EMS and P2 cells is significantly decreased in *formin^cyk-1^(ts)* embryos at 26°C, compared to at 16°C, or compared to in control embryos at 16 or 26°C. There was no significant difference between the average maximum fluorescence intensity of Lifeact::RFP at the division plane in EMS and P2 cells in *formin^cyk-1^(ts)* embryos at 26°C that successfully complete cytokinesis versus in those that fail to divide. Two-tailed t-test ([SupplementaryfFile 1](#supp1){ref-type="supplementary-material"}); n.s., no significance, p\>0.05; \*p≤0.05; \*\*p≤0.01; \*\*\*\*p≤0.0001. Error bars, mean ± SEM, scale bar = 10 µm.](elife-36204-fig4){#fig4}

To determine if robust cytokinesis in EMS and P2 could also withstand perturbations of the F-actin cytoskeleton independent of formin^CYK-1^ activity, we next tested whether cytokinesis in EMS and P2 is resistant to pharmacological inhibition of F-actin polymerization by treatment with low doses of the F-actin inhibitor, LatrunculinA (LatA). Embryos were first permeabilized by *perm-1(RNAi)*, a gene required for normal eggshell assembly ([@bib18]; [@bib83]). Control, non-ts mutant, four-cell stage embryos were incubated with growth medium containing different concentrations of LatA and the lipophilic dye FM 4-64 for at least 10 min before anaphase onset and observed undergoing cytokinesis. Only embryos showing FM 4-64 on the plasma membrane (indicating eggshell permeability), were included in the analysis ([Figure 5A](#fig5){ref-type="fig"}). In embryos treated vehicle control (DMSO only, 0 nM LatA), all four blastomeres divided 100% of the time ([Figure 5B](#fig5){ref-type="fig"}). However, in embryos treated with increasing concentrations of LatA (50, 67, and 80 nM), we observed cell-specific effects of F-actin inhibition, with EMS and P2 cells always dividing at higher frequencies than ABa and ABp cells treated with the same LatA concentration ([Figure 5B](#fig5){ref-type="fig"}). For example, in embryos treated with 80 nM LatA, 100% of ABa (n = 13) and ABp (n = 13) cells failed in cytokinesis, while EMS and P2 cells divided \~25% of the time (EMS: 26%, n = 19; P2: 28%, n = 18). These LatA results phenocopy the cell-type-specific requirement for formin^CYK-1^ activity and again suggest that EMS and P2 are protected against cytokinesis failure when the F-actin cytoskeleton is weakened.

![Cytokinesis in EMS and P2 is more resistant to pharmacological inhibition of F-actin assembly with LatA than in ABa and ABp.\
(**A**) Schematic of the experimental protocol for eggshell permeabilization with *perm-1(RNAi)*, confirmation of eggshell permeabilization with FM 4--64, and subsequent Latrunculin A (LatA) treatment of permeabilized control, non-ts, embryos. Scale bar = 10 µm. (**B**) Schematic of the experimental protocol and graphs showing the cytokinetic outcome for each cell in permeabilized four-cell embryos treated with 0, 50, 67, and 80 nM LatA. Temperature, 21°C. See also [Supplementary file 1](#supp1){ref-type="supplementary-material"}.](elife-36204-fig5){#fig5}

We next investigated whether protection from cytokinesis failure in EMS and P2 is due to cell-intrinsic or -extrinsic regulatory mechanisms. We first eliminated the potential for cell-extrinsic regulation by isolating each individual blastomere from embryos by manual microdissection ([Figure 6A](#fig6){ref-type="fig"}). After removing the eggshell, individual blastomeres were separated at the two-cell stage and allowed to divide again at permissive temperature, followed by another round of sister cell separation, resulting in an isolated ABa/ABp, EMS, and P2 cell from each embryo ([Figure 6A](#fig6){ref-type="fig"}). Upon isolation, the ABa and ABp cells cannot be distinguished from each other, as they are identical in size and fate in the absence of cell-contact-mediated extrinsic signaling from P2 to ABp ([@bib76]; [@bib13]; [@bib74]; [@bib80]; [@bib101]); hence, we refer to these isolated blastomeres as AB daughters (ABd) ([Figure 6A,B](#fig6){ref-type="fig"}). EMS and P2 can easily be distinguished from each other and the ABd by their unique sizes, which do not change upon isolation ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). When upshifted to 26°C, all isolated blastomeres from control and *formin^cyk-1^(ts)* mutant embryos entered mitosis with characteristic cell-cycle synchrony (ABd cells always divided together) and timing (first the Abd cells divide, then EMS, then P2) ([Video 2](#video2){ref-type="video"}). Control blastomeres were able to successfully complete cytokinesis in all cases (10/10 ABd, 10/10 EMS, 12/12 P2 cells complete cytokinesis), while blastomeres isolated from *formin^cyk-1^(ts)* mutant embryos showed cell-type-specific variation in the frequency of cytokinesis failure ([Figure 6B,D](#fig6){ref-type="fig"}; [Video 3](#video3){ref-type="video"}). Similar to equivalent cells in intact embryos ([Figure 6C](#fig6){ref-type="fig"}), isolated ABd blastomeres from *formin^cyk-1^(ts)* embryos always failed in cytokinesis (0/26 ABd cells complete cytokinesis) and isolated P2 cells divided \~30% of the time (7/22 P2 cells complete cytokinesis) ([Figure 6B,D](#fig6){ref-type="fig"}). However, in contrast to in the intact embryo ([Figure 6C](#fig6){ref-type="fig"}) in which EMS cells divide \~33% of the time, isolated EMS blastomeres from *formin^cyk-1^(ts)* mutants never successfully completed cytokinesis when upshifted to restrictive temperature prior to anaphase onset (0/22 isolated EMS cells complete cytokinesis) ([Figure 6B,D](#fig6){ref-type="fig"}). Thus, upon elimination of cell-extrinsic regulation by blastomere isolation, P2 cells still completed cytokinesis at a frequency similar to P2 and EMS cells in the intact embryo, whereas isolated EMS blastomeres always failed in cytokinesis. These results suggest that cell-type-specific variation in cytokinesis failure upon formin^CYK-1^ disruption is controlled cell-intrinsically in P2 and cell-extrinsically in EMS.

![Cell-intrinsic and extrinsic regulation contribute to cytokinesis.\
(**A**) Experimental protocol describing the microdissection, isolation, and separation of individual blastomeres. Steps 1--3 are performed at the permissive temperature (16°C) to ensure the first two-cell divisions occur normally. (**B**) Representative images showing the cytokinetic outcome of cells isolated from control and *formin^cyk-1^(ts)* embryos. Cells that divide successfully are seen as two mononucleate daughter cells. Cells that fail in cytokinesis are seen as single binucleate cells. (**C**) Graph showing the frequency of successful cytokinesis in individual blastomeres in intact *formin^cyk-1^(ts)* embryos upshifted prior to anaphase onset. Note: this data is sub-sampled from the temporally defined upshift experiments shown in [Figure 2B](#fig2){ref-type="fig"}, pooling only those cells upshifted before anaphase onset. ABa and ABp cells have been combined as AB daughters (ABd). (**D**) Graph showing the frequency of successful cytokinesis for blastomeres isolated from control and *formin^cyk-1^(ts)* embryos. Temperature, 26°C; scale bar = 10 µm. See also [Supplementary file 1](#supp1){ref-type="supplementary-material"}.](elife-36204-fig6){#fig6}

###### Isolated blastomeres from a control embryo.

60 s per frame; temperature, 26°C. Green, GFP::plasma membrane; magenta, mCherry::histone2B; scale bar = 10 µm.

10.7554/eLife.36204.020

###### Isolated blastomeres from a *formin^cyk-1^(ts)* embryo.

60 s per frame; temperature, 26°C. Green, GFP::plasma membrane; magenta, mCherry::histone2B; scale bar = 10 µm.

10.7554/eLife.36204.021

During cell fate specification, EMS is cell-extrinsically controlled by cell-cell contact dependent signals from the neighboring P2 cell, which promote cell fate induction and spindle orientation in EMS (for review see \[[@bib93]\]). To determine if direct contact between EMS and P2 regulates cytokinesis in *formin^cyk-1^(ts)* EMS cells, we again isolated sister blastomeres at the two-cell stage but this time did not separate sister cells after the two-to-four cell divisions, leaving ABd-ABd and EMS-P2 paired-doublets intact ([Figure 7A](#fig7){ref-type="fig"}). After temperature upshift to restrictive temperature, all paired blastomeres from control embryos successfully completed cytokinesis, and all paired ABd-ABd blastomeres from *formin^cyk-1^(ts)* mutant embryos failed to divide, as expected ([Figure 7B,C](#fig7){ref-type="fig"}; [Video 4](#video4){ref-type="video"}). In EMS-P2 paired blastomeres from *formin^cyk-1^(ts)* mutants, 29% of P2 cells divided successfully (9/31 P2 cells complete cytokinesis), similar to isolated P2 blastomeres ([Figures 6D](#fig6){ref-type="fig"} and [7C](#fig7){ref-type="fig"}; [Video 4](#video4){ref-type="video"}). Furthermore, 16% of EMS blastomeres in paired EMS-P2 doublets divided successfully (5/31 EMS cells complete cytokinesis) ([Figure 7B,C](#fig7){ref-type="fig"}), in contrast to isolated EMS blastomeres ([Figure 6D](#fig6){ref-type="fig"}) or manually paired EMS-ABd blastomeres (0/15 EMS cells complete cytokinesis), which never divided successfully ([Figure 7C](#fig7){ref-type="fig"}). We did not see a correlation between the success of EMS and the success or failure of cytokinesis in P2, as sometimes both blastomeres successfully completed cytokinesis ([Figure 7B](#fig7){ref-type="fig"}), but other times both failed or one blastomere completed and the other failed in cytokinesis (e.g. [Video 5](#video5){ref-type="video"}). Thus, direct cell-cell contact from P2 is sufficient to mediate protection against cytokinesis failure in EMS.

![Cell-extrinsic regulation of cytokinesis in EMS depends on direct contact with its neighbor cell, P2.\
(**A**) Schematic of the experimental protocol for the isolation of paired-blastomere doublets. Blastomeres are maintained at the permissive temperature (16°C) during preparation of cell doublets (steps 1 and 2) to ensure the first two-cell divisions occur normally. (**B**) Representative images showing the cytokinetic outcome of paired blastomeres from control and *formin^cyk-1^(ts)* embryos. (**C**) Graph showing the frequency of successful cytokinesis for paired blastomeres isolated from control and *formin^cyk-1^(ts)* embryos. (**D**) Schematic showing the measurement of cell-cell contact diameter to calculate the cell-cell contact area between cells in EMS-P2 doublets (**E**). Graphs showing the calculated cell-contact area between EMS and P2 cells in paired doublets isolated from control and *formin^cyk-1^(ts)* embryos. Mean ± SD; two-tailed Mann-Whitney test ([Supplementary file 1](#supp1){ref-type="supplementary-material"}); n.s., no significance, p\>0.05; \*p≤0.05; \*\*p≤0.01; \*\*\*p≤0.001; \*\*\*\*p≤0.0001. Temperature, 26°C; scale bar = 10 µm.](elife-36204-fig7){#fig7}

###### Isolated ABd-ABd (left) and EMS-P2 (right) doublets from control (top) and *formin^cyk-1^(ts)* (bottom) embryos.

60 s per frame; temperature, 26°C. Green, GFP::plasma membrane; magenta, mCherry::histone2B; scale bar = 10 µm.

10.7554/eLife.36204.023

###### Isolated EMS-P2 doublets from *formin^cyk-1^(ts)* embryos, showing combinations of cytokinesis phenotypes.

60 s per frame; temperature, 26°C; green, GFP::plasma membrane; magenta, mCherry::histone; scale bar = 10 µm.

10.7554/eLife.36204.024

While contact with P2 could rescue cytokinesis in EMS upon formin^CYK-1^ disruption, the cytokinesis success frequency for EMS in paired EMS-P2 doublets was lower than in intact *formin^cyk-1^(ts)* embryos (16 vs. 33% respectively; [Figures 7C](#fig7){ref-type="fig"} and [6C](#fig6){ref-type="fig"}). One possibility is that P2 to EMS cell-fate signaling is not as efficient in paired-blastomere doublets as it is in the intact embryo. EMS-P2 signaling is mediated by the interface between the two cells ([@bib41], [@bib42], [@bib43], [@bib44]; [@bib91]; [@bib111]; [@bib7]; [@bib3]; [@bib96]; [@bib50]), and in intact embryos the cells are constrained by the eggshell, pushing them together and resulting in a large contact area between the cells that is reduced upon blastomere isolation. We hypothesized that an increased contact area may enhance EMS-P2 signaling and therefore calculated the cell-cell contact area of the EMS-P2 doublets ([Figure 7D](#fig7){ref-type="fig"}). In *formin^cyk-1^(ts)* paired EMS-P2 doublets in which the EMS cell divided successfully, there was a significantly larger cell-cell contact area compared to in doublets in which the EMS cell failed in cytokinesis (p=0.0266; [Supplementary file 1](#supp1){ref-type="supplementary-material"}; [Figure 7E](#fig7){ref-type="fig"}). There was no significant difference in cell-cell contact area between paired doublets from control embryos and paired doublets from *formin^cyk-1^(ts)* mutants in which EMS divided successfully (p=0.3056; [Supplementary file 1](#supp1){ref-type="supplementary-material"}; [Figure 7E](#fig7){ref-type="fig"}). Because increased cell-cell contact area correlated with an increased probability of successful EMS division and because P2 to EMS signaling is dependent on cell-cell contact, this result suggests a correlation between successful P2 to EMS signaling and successful EMS division when formin^CYK-1^ activity is reduced.

Another marker for successful P2-EMS signaling is spindle orientation in EMS cells. During extrinsic P2 to EMS cell-fate signaling, receptor tyrosine kinase (MES-1) and Wnt^MOM-2^ from P2 activate Src^SRC-1^ and Frizzled^MOM-5^ proteins/receptors in EMS to promote differential cell fate specification and proper spindle orientation during the asymmetric EMS cell division ([Figure 8A](#fig8){ref-type="fig"}) ([@bib41], [@bib42], [@bib43], [@bib44]; [@bib91]; [@bib111]; [@bib7]; [@bib3]; [@bib96]; [@bib50]). Therefore, we tested whether the success or failure of cytokinesis in EMS-P2 doublets from control and *formin^cyk-1^(ts)* mutants correlated with proper orientation of the EMS spindle angle, which reflects proper Src^SRC-1^ and Frizzled^MOM-5^ signaling and successful cell fate specification ([Figure 8B](#fig8){ref-type="fig"}) ([@bib41], [@bib42], [@bib43], [@bib44]; [@bib91]; [@bib111]; [@bib7]; [@bib3]; [@bib96]). In EMS-P2 doublets isolated from control embryos, which always divided successfully, the EMS spindle always aligned near the doublet axis (\~180°), indicating successful P2 to EMS cell-fate signaling ([Figure 8C](#fig8){ref-type="fig"}). In *formin^cyk-1^(ts)* EMS-P2 doublets, EMS spindle orientation varied widely relative to the doublet axis with only 48% of *formin^cyk-1^(ts)* EMS spindles in alignment with the EMS-P2 doublet axis (\>160° relative to the EMS-P2 doublet axis) (15/31 EMS cells; [Figure 8C](#fig8){ref-type="fig"}). This result suggests a potential role for formin^CYK-1^ in this F-actin-dependent P2 to EMS signaling event ([@bib44]). In contrast, in *formin^cyk-1^(ts)* EMS cells that successfully completed cytokinesis, the EMS spindle axis was always aligned with the doublet axis ([Figure 8C](#fig8){ref-type="fig"}), consistent with successful P2 to EMS signaling (5/5 EMS cells) ([@bib7]). Indeed, of the paired *formin^cyk-1^(ts)* EMS cells with normal spindle alignment, 33% (5/15 EMS cells; [Figure 8C](#fig8){ref-type="fig"}) divided successfully, a similar frequency to that observed in intact embryos. Consistent with the cell-intrinsic regulation of cytokinesis in P2, cytokinesis outcome in P2 was independent of EMS spindle orientation and thus P2-EMS cell-fate signaling ([Figure 8C](#fig8){ref-type="fig"}).

![Src^SRC-1^ mediated signaling from P2 provides the cell-extrinsic regulation of cytokinesis in EMS.\
(**A**) Schematic showing EMS and P2 cell-cell signaling during EMS cell fate specification. (**B**) Schematic showing how the EMS spindle angle was calculated. (**C**) Graph showing the EMS spindle angle (as a read-out for proper EMS cell fate specification) for different EMS (left) and P2 (right) cells within paired-blastomere doublets from control or *formin^cyk-1^(ts)* embryos that successfully complete or fail in cytokinesis. Note: the doublets analyzed here are the same as those used in [Figure 7](#fig7){ref-type="fig"}. (**D**) Graph showing the frequency of successful cytokinesis for each cell type in intact *formin^cyk-1^(ts); control(RNAi)* and *formin^cyk-1^(ts); Src^src-1^(RNAi)* embryos. Error bars, mean ± SD. Two tailed Mann-Whitney test ([Supplementary file 1](#supp1){ref-type="supplementary-material"}); n.s., no significance, p\>0.05; \*p≤0.05; \*\*p≤0.01; \*\*\*\*p≤0.0001. (**F**) Model showing the role extrinsic and intrinsic factors in EMS and P2 cytokinesis. Temperature, 26°C; scale bar = 10 µm.](elife-36204-fig8){#fig8}

If signaling from the P2 cell contributes to EMS cell division, rather than just cell-cell contact, blocking the signal pathway in intact *formin^cyk-1^(ts)* embryos should decrease the frequency of successful EMS cell division. To test this, we used RNAi to deplete the non-receptor tyrosine kinase Src^SRC-1^ in *formin^cyk-1^(ts)* mutant embryos and disrupt P2-mediated cell fate specification in EMS ([@bib7]; [@bib3]; [@bib105]) and then monitored cell division in each cell. *Src^src-1^(RNAi)* decreased the frequency of successful division in EMS (2/46 cells) compared with *control(RNAi)* (21/65 cells complete cytokinesis), while the frequency of successful division in P2 was unaffected (29/77 *control(RNAi)* P2 cells; 22/50 *Src^src-1^(RNAi)* P2 cells divided successfully) ([Figure 8D](#fig8){ref-type="fig"}). *Src^src-1^(RNAi)* had no effect on the frequency of successful division in non-ts control embryos ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Thus, the extrinsic mechanism protecting EMS cells from cytokinesis failure after inhibition of *formin^cyk-1^* is dependent on Src^SRC-1^ signaling from P2 cells. Together, our data demonstrate that both intrinsic and extrinsic mechanisms modulate cytokinesis in individual blastomeres in the absence of robust F-actin levels in the contractile ring.

Discussion {#s3}
==========

Here, we used thermogenetics, drug treatment, and embryo microdissection to probe the mechanisms of cell-type-based variation in the regulation of cytokinesis among individual blastomeres within the four-cell *C. elegans* embryo. We found cell-type-specific differences in both the functional levels and temporal window of activity required for formin^CYK-1^ activity, but not myosin-II^NMY-2^ activity, during cytokinesis. We found that, similar to in the one-cell embryo ([@bib25]), formin^CYK-1^ inhibition resulted in cytokinesis failure in ABa and ABp blastomeres. In contrast to the one-cell embryo and ABa/ABp cells, both EMS and P2 blastomeres were protected against cytokinesis failure and divided successfully with consistent frequency upon inhibition of formin^CYK-1^ and in the absence of a robust F-actin contractile ring. This is not likely due to an F-actin-independent role for formin^CYK-1^, as we found cytokinesis in EMS and P2 was also more resistant to LatA, a pharmaceutical inhibitor of F-actin polymerization, than cytokinesis in ABa/ABp. Cell isolation and blastomere pairing experiments revealed that P2 is protected against cytokinesis failure due to cell-intrinsic regulation and independent of contact with other blastomeres. In contrast, we found that EMS is protected against cytokinesis failure by extrinsic regulation due to direct cell-cell contact with P2 and Src^SRC-1^ mediated cell-fate signaling. This work establishes the early *C. elegans* four-cell embryo as a system to study cytokinetic diversity and suggests that, at least in the early *C. elegans* embryo, both cell-intrinsic and extrinsic mechanisms contribute to cell-type-specific cytokinetic diversity. This finding leads to three outstanding questions: First, how can cells divide in the absence of robust F-actin levels in the contractile ring? Second, what are the cell and molecular mechanism(s) that contribute to cytokinetic diversity? Third, what is the advantage of specifically protecting these cells against cytokinesis failure?

Although we could not detect enriched F-actin at the contractile ring in EMS or P2 in *formin^cyk-1^(ts)* embryos at the restrictive temperature, we assume that a 'normal', although F-actin-poor, contractile ring still forms in the cells that divide successfully. In our hands, relative to the one-cell embryo, contractile ring F-actin levels are reduced at the four-cell stage and fluorescent signals from other cortical F-actin populations (such as the cell-cell junctions) make it much more challenging to specifically quantify F-actin levels at the contractile ring in individual cells within multicellular embryos. Thus, we assume that the contractile ring signal in EMS and P2 is simply too dim for us to detect over background signals from other cortical F-actin populations in *formin^cyk-1^(ts)* mutants. In EMS and P2 cells that divide successfully upon formin^CYK-1^ inactivation, contractile ring constriction progresses more slowly ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), suggesting that these cells are utilizing a sub-optimal contractile ring. Indeed, myosin^NMY-2^ is still essential for cytokinesis in EMS and P2, indicating a 'normal' constricting actomyosin contractile ring is likely driving division in these blastomeres. Nonetheless, it is clear that, unlike one-cell embryos and ABa/ABp cells, EMS and P2 blastomeres are still somehow able to divide successfully with a substantially weakened F-actin contractile ring, whether weakened by inhibition of formin^CYK-1^ or application of low doses of Latrunculin A.

An obvious distinction of these more robustly dividing cells is that EMS and P2 divide asymmetrically, whereas ABa and ABp divide symmetrically ([@bib93]; [@bib3]). In the one-cell *C. elegans* embryo, we previously found that anterior-posterior cell polarity and the PAR proteins are essential for robust cytokinesis ([@bib56]). The PAR proteins localize to opposing cortical domains in P2 but are not obviously asymmetrically distributed in EMS ([@bib3]). Little is known about cell polarity establishment and/or maintenance in EMS, but in P2, cell polarity is cell-intrinsically established, though proper orientation of polarity relative to the spindle is dependent on cell-extrinsic signaling from EMS ([@bib3]). It is possible that cell polarity and the asymmetrically functioning PAR proteins ([@bib56]) or G-protein-coupled receptors, which have been implicated in cytokinesis in asymmetrically dividing *Drosophila* neuroblasts ([@bib17]), could promote cytokinesis specifically in EMS and/or P2. Unfortunately, cell polarity in these later divisions is difficult to study, due to the lack of available conditional tools to disrupt cell polarity proteins specifically in four-cell embryos, while allowing normal cell polarity establishment and maintenance in asymmetrically dividing parental cells in the one- and two-cell embryos (i.e. fast-acting ts PAR mutants). While we found that whole embryo PAR protein disruption (by *par-6(RNAi)*) eliminates protection of cytokinesis in EMS and P2 ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}), under these conditions, normal cell fate specification of the four-cell embryo is lost ([@bib12]). Therefore, we cannot distinguish between a specific role for cell polarity during cytokinesis in EMS and P2 cells from a non-specific effect of completely changing the cell-fate patterning of the parental lineages.

One intriguing possibility is that other non-canonical (contractile ring-independent) mechanisms facilitate cytokinesis in EMS and/or P2 such as cytofission or polar cortical relaxation. In mammalian cultured cells, traction-mediated cytofission, driven by daughter cell elongation, crawling, and cell-substrate adhesion, can promote cell division in the absence of an actomyosin contractile ring ([@bib22]; [@bib119]). Cytofission is not likely to be the main driver of cytokinesis in these cells since, even upon blastomere isolation, we do not observe cell crawling behavior or increased daughter cell elongation in EMS or P2. Another possible driver of cytokinesis outside of the contractile ring is polar cortical relaxation, in which reduced cortical contractility outside of the division plane in the polar regions of the cell is proposed to facilitate actomyosin contractile ring constriction at the cell equator ([@bib121], [@bib120]; [@bib64]; [@bib92]; [@bib73]; [@bib67]). Polar cortical relaxation has been proposed to be regulated by Aurora A kinase activity, astral microtubules, and PP1-dependent phosphorylation of ezrin/radixin/moesin (ERM) family proteins ([@bib64]; [@bib92]; [@bib73]). Perhaps in EMS and/or P2, one or more of these cortical polar relaxation pathways outside of the contractile ring is upregulated to ensure robust cytokinesis in these blastomeres.

In EMS, we found that cytokinesis is extrinsically protected and this protection is correlated with cell-fate signaling from P2. Thus, it is possible that extrinsic cell fate signaling has direct downstream effects on the cytokinetic machinery in EMS. Both cell fate specification and asymmetric cell division in EMS are downstream of two partially redundant signaling pathways that influence similar downstream targets and depend on cell-cell contact between P2 and EMS: Wnt/Frizzled and Receptor Tyrosine Kinase (RTK)/Src signaling ([@bib41], [@bib42], [@bib43], [@bib44]; [@bib91]; [@bib111]; [@bib7]; [@bib3]; [@bib96]; [@bib105]; [@bib8]). During this cell fate specification event, the Wnt^MOM-2^ ligand from P2 activates Frizzled^MOM-5^ receptors on the surface of EMS ([@bib91]; [@bib111]; [@bib7]; [@bib105]). In parallel, transmembrane-domain-containing RTK^MES-1^ on P2 stimulates the same RTK^MES-1^ on EMS in trans, promoting Src^SRC-1^ activation in both cells ([@bib7]; [@bib70]; [@bib105]). Indeed, we found that both a high cell-cell contact area and proper spindle orientation, two indicators of successful cell fate signaling from P2 to EMS, are highly correlated with successful cytokinesis in EMS ([Figures 7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}), and that depletion of Src^SRC-1^ specifically causes division failure in the EMS cell, but not the P2 cell. In support of cell-fate signaling in cytokinetic diversity, both Wnt and Src-family kinase signaling have been implicated in both positive and negative regulations of cytokinesis in other cell contexts ([@bib27]; [@bib36]; [@bib60]; [@bib102]; [@bib59]; [@bib5]; [@bib95]; [@bib122]; [@bib53]; [@bib57]; [@bib58]), and in human cancer cell lines Wnt5a, its receptor Frizzled^Fz2^, as well as a mediator of Wnt signaling, Dishevelled^Dvl2^, all localize to the midbody at the division plane ([@bib36]; [@bib62]). Thus, Wnt and/or Src cell fate signaling pathway components may themselves, or via their downstream targets, function to protect against cytokinesis failure in the absence of a robust actomyosin contractile ring.

Robust cytokinesis in P2 is cell-intrinsically regulated and independent of contact with other blastomeres within the four-cell embryo. The *C. elegans* P lineage forms the germline and cells within that lineage (including P2) inherit distinct levels of cellular organelles, cell polarity proteins, and transcriptional regulators compared to the other three blastomeres in the four-cell embryo. In flies, germ lineage cells also divide more robustly (by a specialized cytokinesis called cellularization) and are resistant to some loss of function mutations in Anillin that completely block cytokinesis in somatic lineage cells ([@bib34]). One possibility is that germline-specific inherited factors promote cytokinetic robustness in that lineage. For example, CAR-1 is an Sm-like protein essential for cytokinesis in the one-cell *C. elegans* embryo and is specifically inherited in the P lineage, including the P2 cell, via association with germline enriched non-membrane-bound, ribonucleoprotein (RNP) organelles called P-granules ([@bib4]; [@bib103]). Perhaps the higher levels of CAR-1 (or of other P-granule associated factors) in P2 protect against cytokinesis failure in this blastomere.

What advantage is gained from protection of these specific cell lineages against cytokinesis failure upon formin^CYK-1^ inactivation? In the early *C. elegans* embryo, six founder cells (AB, E, MS, C, D, and P4; [Figure 1A](#fig1){ref-type="fig"}) give rise to all cell lineages within the adult worm. In the four-cell embryo, EMS and P2 are upstream of founder cell formation within their lineages, while ABa and ABp are descendants of the first-born founder cell, AB ([Figure 1A](#fig1){ref-type="fig"}). We speculate that the EMS and P2 cells may be afforded extra levels of protection to ensure that they give rise to their founder cell descendants (E, MS, C, D, P4; [Figure 1A](#fig1){ref-type="fig"}), ensuring that all fates and lineages are represented in the developing worm. Additionally, both EMS and P2 undergo asymmetric cell divisions with each daughter cell inheriting specific organelles, transcriptional regulators, and other factors, so these blastomeres may undergo more selective pressure to develop protective mechanisms to ensure successful asymmetric cell division.

Together, our data show that both cell-intrinsic and extrinsic regulatory mechanisms contribute to cytokinetic diversity and promote robust cytokinesis when the contractile ring is weakened in specific cell types within the four-cell *C. elegans* embryo. Due to the similarities between cell fate signaling and cytokinetic machinery between worms and humans, we predict that similar regulation contributes to cytokinetic variation within cells of the human body to promote sensitivity or resistance to cytokinesis failure and therefore potentially mediate the onset or prevention of cell-type-specific pathologies.

Materials and methods {#s4}
=====================

Strain maintenance {#s4-1}
------------------

*C. elegans* were maintained on standard nematode growth media (NGM) plates seeded with OP50 *E. coli* as previously described ([@bib15]). Strain names and genotypes used in this study can be found in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

Temperature control {#s4-2}
-------------------

Control and ts strains were maintained in an incubator (Binder) at a permissive temperature (16.0 ± 0.5°C). Live imaging was performed in a room with homeostatic temperature control set to the desired temperature at least 1 hr before the experiment. The temperature of the specimen was continuously monitored using at least three thermometers either attached to the objective or placed on the stage next to the sample.

Rapid temperature shifts {#s4-3}
------------------------

Rapid temperature shifts were performed using a custom-built fluidic system called the Therminator (Bioptechs; \[[@bib25]\]) with one water/isopropanol bath maintained at permissive temperature (16.0 ± 0.5°C) and a second bath at the restrictive temperature (26.0 ± 0.5°C).

Embryo mounting and microdissection {#s4-4}
-----------------------------------

For imaging intact embryos, young gravid hermaphrodites were dissected in 16°C M9 buffer ([@bib15]) and recovered embryos were mounted on a thin 2% agar pad as previously described ([@bib45]). In [Figure 3](#fig3){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, and [Figure 5](#fig5){ref-type="fig"}, embryos were mounted with the 'hanging drop' method ([@bib26]) using a SecureSeal spacer (Electron Microscopy Sciences, \#70327--9S) to allow positioning of the embryo in the desired orientation.

For isolated blastomere imaging, young gravid hermaphrodites were dissected in ddH~2~0, and then treated with alkaline hypochlorite to remove the eggshell. Embryos were placed in Shelton's growth medium \[0.288 mg/mL inulin (Sigma Aldrich, \#I2255), 2.88 mg/mL poly(vinylpolypyrrolidone) (Sigma Aldrich, \#P0930), 0.0059x BME vitamins (Sigma Aldrich, \#B6891), 0.0059x chemically defined lipid concentrate (ThermoFisher, \#11905--031), 0.59x Penn-Strep (ThermoFisher, \#15140--122), 0.52x *Drosophila* Schneider's Medium (ThermoFisher, \#21720--024)\], and 0.35x fetal bovine serum (ThermoFisher, 10438--018) ([@bib101]) before removal of the vitelline envelope and blastomere dissociation by repeated aspiration and ejection through a 30 μm needle (World Precision Instruments, \#TIP30TW1) ([@bib63]). In all cases, embryo isolation and blastomere dissections were performed at 16°C to allow development to the four-cell stage. For imaging, the isolated blastomeres were mounted in 20 μL of Shelton's growth medium in a Peltier-driven temperature-controlled chamber (26°C) (Oasis, Bioptechs, \#15--160).

Live cell imaging {#s4-5}
-----------------

Embryos were imaged using a spinning disc confocal unit (CSU-10; Yokogawa Electric Corporation) with Borealis (Spectral Applied Research) on an inverted microscope (Ti; Nikon) and a charge-coupled device camera (Orca-R2; Hamamatsu Photonics). Z-sectioning was done with a Piezo-driven motorized stage (Applied Scientific Instrumentation), and focus was maintained using Perfect Focus (Nikon) before each Z-series acquisition. An acousto-optic tunable filter was used to select the excitation light of two 100 mW lasers for excitation at 491 and 561 nm for GFP and mCherry, respectively (Spectral Applied Research), and a filter wheel was used for emission wavelength selection (Sutter Instruments). The system was controlled by MetaMorph software (Molecular Devices).

For most experiments, a 20 × 0.75 N.A. dry PlanApochromat objective was used, with 2 × 2 binning and 11 × 2 μm Z-sections collected every 60 s to measure cytokinetic progression, using embryos expressing GFP::PH and mCherry::H2B ([@bib4]) to label the plasma membrane and chromosomes respectively. In [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, the F-actin markers PLST-1::GFP and LifeAct::RFP ([@bib31]) were imaged with a 60 × 1.4 N.A. oil immersion PlanApochromat objective, with 2 × 2 binning and 4 × 0.5 μm Z-sections at the cortex. In [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, a 60 × 1.4 N.A. oil immersion PlanApochromat objective, with 2 × 2 binning and 13 × 2.5 μm Z-sections collected every 30 s to measure cytokinetic progression with the GFP::PH and mCherry::H2B markers. In [Figure 3](#fig3){ref-type="fig"}, CYK-1::GFP was imaged at a single timepoint at the early stages of ingression using a 60 × 1.4 N.A. oil immersion PlanApochromat objective, with 2 × 2 binning and 35 × 1 μm Z-sections. In [Figure 4](#fig4){ref-type="fig"}, the F-actin markers, LifeAct::RFP and eGFP::Utrophin^ABD^ ([@bib115]) were imaged with a 60 × 1.4 N.A. oil immersion PlanApochromat objective, with 2 × 2 binning. In [Figure 4](#fig4){ref-type="fig"} and [Figure 4 -- figure supplements 1](#fig4s1){ref-type="fig"} and [3](#fig4s3){ref-type="fig"}, 13 × 2 μm Z-sections were used. In [Figure 4 - figure supplement 2](#fig4s2){ref-type="fig"}, 65 × 0.5 μm Z-sections were used. In [Figure 5](#fig5){ref-type="fig"}, GFP::PH, mCherry::H2B, and FM 4--64 were imaged with a 40 × 0.95 N.A. dry PlanApochromat objective, with 2 × 2 binning and 13 × 2.5 μm Z-sections. In [Figures 6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}, GFP::PH and mCherry::H2B in isolated blastomeres were imaged using a 40 × 0.95 N.A. dry PlanApochromat objective, with 2 × 2 binning and 9 × 2 μm Z-sections. In [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, cells in intact embryos were imaged using a 40 × 1.25 N.A. water immersion Apochromat objective, with 1 × 1 binning and 51 × 1.0 μm Z-sections.

Image analysis {#s4-6}
--------------

MetaMorph (Molecular Devices) and ImageJ (National Institutes of Health \[[@bib97]\]) software were used for all data analyses. Cytokinetic phenotypes were scored using maximum projections of the Z-sections collected over the course of cell division. Cells were only scored if imaging began before anaphase onset and continued until the next cell cycle, when the daughter cell nuclei underwent anaphase and/or division failure. For the phenotypic analysis in [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, cells were binned into five cytokinetic phenotypes; 'completes'=cell under observation divided successfully and the contractile ring remained closed when the daughter cell nuclei entered the next division cycle; 'fails, full constriction'=contractile ring constriction continues until no observable gap is seen with the PH::GFP membrane marker, but then regresses and cytokinesis fails; 'fails, partial constriction'=the cytokinetic furrow tip ingresses such that a double membrane forms ([@bib67]) but the contractile ring does not close before regressing; 'fails, weak constriction,' slight furrow ingression occurs, with weak membrane deformation, before regressing; 'fails, no constriction,' no furrowing or contractile ring ingression is observed following anaphase onset. Maximum intensity projections of GFP::PH and H2B::mCherry were used to monitor the time of anaphase onset and cytokinetic phenotype. In [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, contractile ring diameter was measured by creating an X-Z projection so the whole contractile ring could be observed. For each time point, the Z-plane at which the ring diameter was widest was used for this measurement. Contractile ring diameter was plotted as a percentage of the initial diameter (at metaphase) over time. In [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, the cell volume of isolated blastomeres was estimated by measuring the maximum cross-sectional area of each blastomere prior to anaphase (during mitosis), then calculating the radius and volume, assuming that the cells are spherical. Radius = √(Area/π); Volume = (4πr^3^)/3. The volume of cells in intact embryos was calculated as the sum of 23 or more 1 μm Z-section volumes, by measuring the cell area at each Z-plane. In [Figure 7E](#fig7){ref-type="fig"}, the area of contact between EMS and P2 was estimated assuming a circular contact interface and measuring the diameter of this interface in a maximum projection of multiple Z-sections, in the frame prior to anaphase onset in EMS. In [Figure 8C](#fig8){ref-type="fig"}, the EMS spindle angle was defined in the X-Y plane by drawing a line through the two chromosome masses in the first frame after anaphase onset in the EMS cell; this angle was measured relative to the long axis of the EMS-P2 doublet.

For the quantitative image analysis in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, F-actin levels in the one-cell embryo were analyzed using the maximum or sum intensity projection images of a four optical slice Z-section through the cell cortex. In [Figure 4](#fig4){ref-type="fig"}, F-actin levels in individual blastomeres in the four-cell embryo were analyzed from a Z-section through entire embryo using a maximum intensity projection (rather than a sum projection) to (1) increase the enriched cortical signal (where F-actin is localized), (2) reduce the effect of cell volume and position within the embryo on the measurements, and (3) to reduce the contribution of fluorescence signals analyzed from cytoplasm, cell-cell junctions, and adjacent cells. Line scans were 30.83 μm (P0 cells) 17.13 μm (EMS, ABa, and ABp cells) or 13.70 μm (P2 cells) long by 11.99 μm (P0 cells) or 3.42 μm (EMS, ABa, ABp, and P2 cells) wide, along the cell length perpendicular to the division plane. When cell polarity could be observed (in P0, EMS, and P2), the line was always oriented in the anterior to posterior direction. These line scans were normalized by subtracting the average of the initial and final 4.11 μm. Graphs showing the average fluorescence intensity at the division plane use the average value of the central 4.11 μm region of these line scans. Line scans were 13.70 μm long by 3.43 μm wide, along the cell length perpendicular to the division plane. When cell polarity could be observed (EMS and P2), the line was always oriented in the anterior to posterior direction. These line scans were normalized by subtracting the average value for a line scan adjacent to the embryo. Graphs showing the average fluorescence intensity at the division plane use the average value of the central 2.74 μm region of these line scans. In [Figure 3](#fig3){ref-type="fig"}, accumulation of formin^CYK-1^::eGFP was analyzed using a Z-series maximum intensity projection to select for the signal from the cortex next to the coverslip. In [Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}, formin^CYK-1^::eGFP was analyzed using a Z-series sum intensity projection through the cell to measure the total levels of formin^CYK-1^::eGFP at the division plane (including cytoplasmic signal). In multicellular *C. elegans* embryos, we prefer maximum over sum intensity projection analysis to quantify fluorescence intensity differences, especially for cortically enriched proteins (e.g. formin^CYK-1^::eGFP, F-actin). Accurately comparing fluorescence intensity levels in the multicellular four-cell embryo is more challenging than in the one-cell embryo because: (1) individual cells within the four-cell embryo vary in both their position within the four-cell embryo and in their axis orientation during cell division (ABa and ABp divide perpendicular to the long embryo axis whereas EMS and P2 divide parallel to this axis); (2) there is rotational variation of individual embryos relative to the coverslip in every image series; (3) individual cells within the four-cell embryo are of different volume and thus occupy different numbers of Z-sections within the image stack, (4) signals from adjacent cells contribute differently to the fluorescence intensity measured for each cell within the four-cell embryo, and (5) formin^CYK-1^::eGFP is largely enriched at the cell cortex, but also occupies the cell cytoplasm. These issues impact sum projection analysis to a much greater extent than maximum projection analysis and in our opinion, render sum projection analysis less reliable for measuring the levels of formin^CYK-1^::eGFP (or other cortical proteins) at the contractile ring in the four-cell embryo.

CRISPR {#s4-7}
------

Formin^CYK-1^::eGFP expressing worms were generated using CRISPR/Cas9 to tag the endogenous *cyk-1* gene locus using a method described previously ([@bib29]). The original self-excising cassette (SEC) repair plasmid pDD282 was modified, incorporating a 3' homology arm (570 bp of *cyk-1* coding sequence, with silent mutations to prevent gRNA/Cas9 cutting) and a 5' homology arm (690 bp of the 3' UTR of *cyk-1* and adjacent gene *rfl-1*) - for insertion of eGFP at the C-terminus of *cyk-1* (pJC340). pJC346 expresses the Cas9 protein, as well a gRNA, which was specifically modified to target *cyk-1* at the C-terminus (GCGAGAAGATCGTCTGTTGA[TGG]{.ul} (PAM site underlined)) and was based on the plasmid pDD162. These were injected (pJC340, 10 ng/μL; pJC346, 55 ng/μL) into N2 young adults along with co-injection markers as described ([@bib29]). Selection was performed as described ([@bib29]) and rolling worms expressing formin^CYK-1^::GFP were isolated. Homozygous formin^CYK-1^::GFP integrants were heat-shocked for 5 hr at 32°C to remove the SEC ([@bib29]). Successful integration and SEC excision were confirmed by PCR sequencing and visualization of formin^CYK-1^::GFP on the spinning disc confocal microscope described above (see Live cell imaging). See [Supplementary file 2](#supp2){ref-type="supplementary-material"} for details of plasmids and sequences. Embryonic viability was scored by allowing individual hermaphrodites to lay eggs for \~24 hr at 20°C and each individual adult was transferred to a fresh plate each day for a total of \~72 hr. The number of progeny (embryos and larvae) were counted for each plate 24 hr after removal of the adult hermaphrodite.

RNAi {#s4-8}
----

Exonic sequences from the desired gene were cloned into the multiple cloning site of the L4440 vector using standard cloning techniques and then transformed into HT115 *E. coli* using CaCl~2~ transformation as previously described ([@bib112]). RNAi primers and template DNA for each gene are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. RNAi feeding bacteria were grown in Luria broth with ampicillin (100 μg/mL) for 8--16 hr at 32°C. 300 μL of this culture was plated on RNAi plates (nematode growth media agar plates ([@bib15]) supplemented with 50 μg/mL ampicillin and 1 mM IPTG). These plates were allowed to dry and grow at 32°C for 24--48 hr. L1 stage worms were plated on RNAi plates and incubated at 16°C for 72 hr before dissection to obtain embryos.

Eggshell permeabilization and LatruculinA treatment {#s4-9}
---------------------------------------------------

L1 stage worms were plated on *perm-1(RNAi)* plates and incubated at 21°C for \~60 hr, to permeabilize the embryos by preventing normal eggshell formation ([@bib18]; [@bib83]). Young adult worms were picked directly into Shelton's growth medium (SGM, see *Embryo mounting and microdissection* above) and dissected to release early embryos. Four-cell stage embryos were then washed three times into SGM containing various concentrations of Latrunculin A (Tocris Bioscience, \#3973, stored as a 2.5 mM stock in DMSO at −80°C), as well as 10 μM FM 4-64 (Thermo Fisher Scientific \#T13320). Embryos were then transferred to a drop of the same growth medium on a No. 1.5 22 × 22 mm coverslip, and mounted with the 'hanging drop' method ([@bib26]) using a SecureSeal spacer (Electron Microscopy Sciences, \#70327--9S) to avoid changing the media composition or compressing the embryos. Successful eggshell permeablization was confirmed by the presence of the FM 4--64 dye on cell membranes in the first time point of the time lapse image series.

Statistical analysis {#s4-10}
--------------------

Statistical significance was calculated in GraphPad Prism and Microsoft Excel. See also [Supplementary file 1](#supp1){ref-type="supplementary-material"} and the figure legends for a detailed description of statistical tests used for individual experiments.
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\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Cell-intrinsic and extrinsic control of cytokinetic plasticity\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor (Mohan Balasubramanian) and a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The reviewers found the thermogenetics approach very interesting and also believe that the cell-type specific function of formin as novel and exciting. However, some major concerns were raised, which are reproduced verbatim below. In short, I see five key points that need consideration and addressing. I believe the suggested experiments may alter your conclusions significantly and may take well over two months to complete (our limit for revisions) and hence our decision to not consider it further.

However, if you are able to address the key points that I list below, we will be happy to consider a new manuscript from you. This we expect will move your story from being descriptive to mechanistic.

Main points to address: Many of these points have been raised by two or all of the reviewers.

1\) Cyk1 ts mutant, whether it is defective for actin assembly at 15C, whether Cyk1 has an actin independent function. (raised by reviewer 2)..

2\) Accuracy of quantitation approach of actin levels, use of other markers and other considerations raised by reviewers 2 and 3.

3\) The strength of evidence on whether other formins are dispensable for cytokinesis in the 4 cell embryo (all reviewers).

4\) Links between polarity proteins and cell type specific cytokinesis (raised by 2 and 3).

5\) Links between Wnt/Src and cell type specific cytokinesis (reviewers 1 and 2).

Reviewer \#1:

The process of physical separation of two cells, Cytokinesis, is regulated by numerous cell autonomous and non-autonomous cues. While constriction of an equatorial actomyosin network powers plasma membrane closure, the ability to regulate its spatiotemporally varies among cell types. In this work the authors present a thorough illustration of this principle in 4 cell stage of *C.elegans*. Using fast acting temperature sensitive alleles the authors show that cell fate influences the ability of a cell type to withstand Formin and actin perturbation. This is regulated both in a cell intrinsic and extrinsic fashion requiring neighbouring cell contacts.

The methodology and presentation of data is undoubtedly impressive. However, several conclusions appear to be an over-estimates the data. The text is well written yet offers little information on the process of cytokinesis and focuses almost exclusively on its outcome and failure. The authors on several occasions make categorical statements that at least to me appear inconclusive.

Major Points:

1\) Figure 3-figure supplement 1

\"This suggests that another formin-related protein is not compensating for loss of formin CYK-1 activity\"

I concur that none of the formins at least individually show a strong synthetic defect with CYK-1ts. However that doesn\'t rule out the possibility that formins may act synergistically. Therefore, the conclusive statement doesn\'t stand merit.

2\) \"This suggests that EMS-P2 cell-cell contact mediates cell-extrinsic cues that protect against cytokinesis failure due to forminCYK-1 disruption in EMS\".

The set of observations leading to this particular conclusion involves examining EMS-P2 pair after CYK-1 inactivation. Currently, it is not possible therefore to distinguish between the specific requirements of P2 versus requirement of an unspecified neighbouring cell. Whether the ABp-EMS pair would behave similarly cannot be hypothesised. Therefore the conclusion, I believe, is the presence of a neighbouring cell. Unless the authors prove or show specific mechanisms originating from P2, the current conclusion seems a stretch.

3\) The Cell-extrinsic vs intrinsic angle indeed adds a dimension to this work. One would be curious to know, particularly in the EMS, whether the myosin-II ts yields an expected phenotype.

4\) Figure 5.

I am unable to follow the logic here clearly. The spindle morphology has a direct impact on cytokinesis (beyond its spatial positioning). Spindles are therefore a cause of any cytokinesis defect under study. Proper spindle alignment (Figure 5E), does not guarantee successful cytokinesis. In CYK-1 ts, the distribution is visibly wider with some cases of proper spindle alignment and yet cytokinesis fails. I agree cases of successful cytokinesis seems to be correlative to proper spindle alignment. But this as a whole is incomplete and inconclusive. The authors do not make an attempt to conclude this section and one fails to see what exactly the authors allude to here.

Reviewer \#2:

This manuscript reports the cell-type dependent phenotypes of a temperature-sensitive allele of cyk-1 formin in 4-cell stage *C. elegans* embryos. Inactivation of this f-actin nucleator during the first cell division by temperature upshift results in highly penetrant cytokinesis failure. Interestingly, while division of ABa and ABp cells was strongly inhibited by a similar temperature upshift during 4 cell stage, P2 and EMS divisions were more resistant and even at 26°C (the highest temperature that allows robust cell divisions in the wild type embryos) about 30-50% of these divisions completed successfully. Further, by blastomere isolation and recombination experiments, the authors revealed that cytokinesis of the EMS cell with reduced CYK-1 activity depends on the cell-cell contact between the EMS and P2 cells while the P2 division is independent of the contact with other cells. Based on these observations, the authors conclude that both the cell-intrinsic and extrinsic mechanisms protect against division failure due to defective contractile ring.

Establishment of an experimental system that allows further study of cell-type dependent variation in the mechanism of cytokinesis is a highly valuable achievement. However, there are major shortfalls in the current manuscript as below.

1\) The authors implicitly assume that 1) the temperature sensitivity of cytokinesis failure is derived of the temperature sensitive inactivation of CYK-1 (ts) mutant protein and 2) the levels of residual CYK-1 activity after temperature upshit are invariable across the four different cell types (or completely inactivated in all the four cells). However, neither of these assumptions have been confirmed.

In Davies (2014), they compared CYK-1 FH1FH2C fragments with and without the L1015H mutation found in the cyk-1(ts) allele and showed that this mutation inactivates the in vitro actin polymerizing activity at 25°C. However, it remained unclear whether the CYK-1 mutant is active at 15°C or not (this actually should have been examined at the publication of the 2014 paper). Thus, currently, we can\'t exclude the possibility that the CYK-1 L1015H mutant protein is inactive at 15°C as well, and the mutant cell can complete cytokinesis at 15°C, but not at higher temperature, because of the presence of an unknown redundant pathway whose activity is intrinsically temperature-sensitive. If this was the case, the cell-type dependent ts phenotypes would not be reflecting the variable responses to the defective actin polymerisation but be indicating the variable activities of this redundant pathway.

Even if the temperature-sensitive cytokinesis failure of cyk-1(ts) was caused by the temperature-sensitive activity of the mutant protein, currently, there is no direct evidence that the cellular CYK-1 activity is inactivated uniformly across the four cell types. The cell type specificity might be caused by the variable level of the residual activity of CYK-1. If so, observed data should be interpreted as indicating the variations in a cellular mechanism for the expression of the CYK-1 activity, rather than the plasticity against the defective contractile ring.

2\) The manuscript is rather descriptive and misses clear insight into the molecular mechanisms. In Jordan (2016), the authors reported the synthetic effects between the cyk-1(ts) and depletion of PAR proteins. Are the expression levels/cortical localization of the PAR proteins in the 4 cell types consistent with the cell type dependent phenotypes in cyk-1(ts) embryos? Does inactivation of the WNT or SRC signalling affect cytokinesis of the cyk-1(ts) mutant EMS cell?

3\) Data about the f-actin levels in the cleavage furrow (Figure 3) are not convincing. About 50\~70% of the cyk-1(ts) mutant EMS and P2 cells fail cytokinesis while 30\~50% complete it. The successful cells might have more robust contractile ring than the unsuccessful ones. Successful cells and failed cells should be analyzed separately as the author did in Figure 5---figure supplement 1.

Reviewer \#3:

The mechanisms of cytokinesis remain elusive despite decades of work. The lack of resolution of a universal mechanism may stem in part from the employment of a wide range of model cell types. It is unclear whether reported differences reflect cell-type specific distinctions or a general absence of redundant mechanisms in some systems. Davies and colleagues compared the molecular requirements for cytokinesis of several cells in the early *C. elegans* embryo. They combined the well-characterized fate specification of the cells with powerful, time-resolved perturbations of major conserved cytokinesis proteins via temperature sensitive mutant alleles. The manuscript is a technical tour-de-force, with exquisite cell manipulation experiments in addition to temperature shift work with intact embryos. It is exceptionally comprehensively referenced, and will set a new standard for the field. That said, since the authors are not able to resolve the problem of how certain cells divide following strong reduction of F-actin by CYK-1 (ts) upshift, I recommend a finite list of things to try and to consider. I feel confident that after these concerns are addressed, this manuscript will be suitable for publication in *eLife*.

Major Points:

1a) F-actin levels and distribution need to be quantified and presented for the AB lineage, comparing control and formin ts shifted embryos.

1b) The lack of an effect of targeting other formins is not fully satisfying, since no positive control is provided to ensure that they are depleted. One potential way to augment the exploration of these other formins is to consult a recent comparative transcriptomics study that may be able to verify which formins are expressed in the various early blastomeres (Tintori et al., Dev. Cell. 2016).

1c) Have the authors verified their analysis of F-actin levels using a second, distinct F-actin probe (LifeAct or the ABD of moesin)? It seems possible that these probes detect slightly different sub-populations of F-actin. I do not expect the authors to introduce fluorescently-labeled phalloidin or recombinant G-actin into embryos to distinguish different F-actin pools as has been done (see for example Burkel, von Dassow and Bement, Cytoskeleton 2007). The authors could label a non-formin-nucleated pool with a GFP-actin (Chai, Ou and colleagues, Nature Protocols, 2012).

1d) The authors should examine the localization of fluorescently-tagged CYK-1 during cytokinesis of the 4 cells they study.

2\) In cases where cytokinesis is more successful than expected (insensitive cells), is initiation late? I.e. is overall duration longer than expected?

3\) It would seem not outside the scope of this paper to combine the cyk-1 ts and a par mutant and shift the P2 after dissociation, to determine the role of polarity in protecting the P2.

4\) Can the authors explain why higher temperatures do not always produce more severe phenotypic classification (i.e. Figure 1C, AB lineage, myosin and cyk-1 ts)? Is there compensation for the loss of function by an increase in things jiggling around? Similarly, why is shifting earlier not always worse (i.e. Figure 2B, EMS and P2, formin mutant)? Are un-scored embryos dying and scored, live ones less severely affected somehow?

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Cell-intrinsic and extrinsic mechanisms promote cell-type specific cytokinetic diversity\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Anna Akhmanova (Senior Editor), Mohan Balasubramanian (Reviewing Editor), and three reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

The reviewers have raised a number of points and I have compiled the list of essential revisions below. The points raised do not require any additional experiments (unless you already have new data), but I would encourage you to state the conclusions without exaggeration and explain all of the points raised below satisfactorily.

In the discussion between reviewers, point 5 was emphasised as being important by ALL three reviewers.

1\) Unfortunately, our suggestion of repeating an in vitro experiment to check the actin polymerization-promoting activity of the mutant version of CYK-1 at 16°C was neglected (or not presented). However, the authors measured the levels of F-actin in the contractile ring in the mutant embryos. Since the readout of this assay is the influence of the formin mutation on the complex cellular process of F-actin polymerization, it can also address our question though only indirectly. Anyway, irrespective of cell types and probes, the furrow F-actin levels in cyk-1(ts) mutant embryos at 16 °C were lower than those in wildtype embryos at 16 °C (Figure 4E, Figure 4---figure supplement 1C and Figure 4---figure supplement 3B). This suggests that CYK-1 L1015H mutant protein is not fully functional as the wildtype protein, as the authors admitted in the letter of rebuttal. However, although I am afraid that I might have just overlooked, I could not find any mention about this fact, which is important for the readers to understand the technical and conceptual limitation of the authors\' approach, in the main text.

In the rebuttal, the authors wrote, \"we have now measured the levels of F-actin in the contractile ring at both permissive and restrictive temperatures (16°C and 26°C) in control and formin cyk-1(ts) mutant embryos\". However, I couldn\'t find any data for the ring F-actin levels in wildtype embryos at the restrictive temperature. Knowing now that CYK-4 ts mutant protein is not fully functional even at the permissive temperature, we can\'t exclude the possibility that the cytokinesis phenotype by acute temperature upshift might be triggered by acute inactivation of an unknown redundant mechanism for actin polymerization, which might be responsible for protecting the EMS and P2 cells from cytokines failure. In case of Figure 4E \'P2 cells\', for example, drop of F-actin levels in cyk-1(ts) embryos from \~3 to \~0 by temperature upshift could be due to a) further inactivation of the mutant CYK-1 protein or b) inactivation of an unknown factor that contributes to the ring actin polymerisation. Data about F-actin levels in the wildtype embryos will be helpful for discriminating these possibilities. If the temperature upshift didn\'t affect the F-actin levels in the wildtype embryos or promoted it, this would provide a strong support for scenario a). On the contrary, if the temperature upshift drops the F-actin levels in the wildtype embryos from \~6 (16°C) to \~3 (26°C) or lower, it would be reasonable to conclude that the scenario b) is more likely.

2\) I am afraid that I might be completely wrong, but I guess that the authors might already have the data of F-actin levels in wildtype embryos at 26°C since this is a very basic control. Whichever the results were, with the new data of the latrunculin A-sensitivity, the authors\' key discovery in the current manuscript that the EMS and P2 cells are protected against cytokinesis failure due to the perturbed actin cytoskeleton will not be affected. Depending on the results, the authors might need to revise their basic assumption that the temperature shift causes a phenotype by acutely inactivating the mutant protein with a \'fast-acting ts mutation\', on which they have been relying in previous publications. However, it is highly unnatural if the data of F-actin levels in wildtype embryos at 26°C is not shown. I strongly recommend showing the data of the F-actin levels in wildtype embryos at 26°C in at least one of Figure 4E, Figure 4---figure supplement 1C or Figure 4---figure supplement 3B (or Figure 1---figure supplement 1 although this is not really ideal), and properly discuss their implications on the possible mechanism for the acute induction of cytokinesis failure by temperature shift.

3\) Figure 4---figure supplement 2C \'EMS\'

A light blue half circle, probably derived from the markers of the graph points, is overlaid on a cartoon of a 6-cell stage embryo.

4\) Figure 3---figure supplement 1

If we simply compare the control P2 cells (30 completion vs 40 failure, total n=70) with the inft-2(RNAi) (27 completion vs 14 failure, total n=41) by Fisher\'s exact test, the p-value will be 0.030. By Pearson\'s chi square test, it will be 0.032. This might be implying that inft-2, which is expressed at the 4-cell stage, might have an inhibitory role in the ring F-actin polymerization in the P2 cells although this is perfectly consistent with the authors\' statement \"we found that individual depletion of the other formin-related proteins did not decrease the frequency cytokinesis failure in any of the 4 blastomeres in formin cyk-1(ts) mutants.\" These simple calculations might not be appropriate for a complex dataset such as in Figure 3---figure supplement 1, to which care about multiple comparisons has to be paid, and the authors might have performed proper corrections, which might have made it \>0.05, the significance level used in other figures. More details about the statistical method for interpretation of this valuable dataset should be provided.

5\) The intensity of both F-actin and formin is calculated in various panels of Figure 1 and Figure 3 using maximum intensity projection. In my opinion, they should use sum intensity projection.

10.7554/eLife.36204.033

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> Main points to address: Many of these points have been raised by two or all of the reviewers.
>
> 1\) Cyk1 ts mutant, whether it is defective for actin assembly at 15C, whether Cyk1 has an actin independent function. (raised by reviewer 2)..
>
> 2\) Accuracy of quantitation approach of actin levels, use of other markers and other considerations raised by reviewers 2 and 3.

To address reviewer points 1 and 2, we have now measured the levels of F-actin in the contractile ring at both permissive and restrictive temperatures (16ºC and 26ºC) in control and *formin^cyk-1^(ts)* mutant embryos using multiple fluorescently-tagged F-actin reporters (Lifeact::RFP, GFP::PLST-1, and GFP::Utrophin^ABD^). We found that contractile ring F-actin levels were lower in *formin^cyk-1^(ts)* mutant embryos than in control embryos at 16ºC (permissive temperature), and contractile ring F-actin levels were undetectable in *formin^cyk-1^(ts)* mutant embryos at 26ºC (restrictive temperature). This suggests the *formin^cyk-1^(ts)* mutant is indeed temperature sensitive for formin^CYK-1^-mediated F-actin polymerization at 26ºC and, despite providing sufficient formin^CYK-1^ activity to support organismal viability and germline function (Jordan et al., 2016), is not fully wildtype at 16ºC. To address these overall reviewer concerns in a different way, we also targeted F-actin polymerization independent of formin^CYK-1^ activity, by treating embryos with a pharmaceutical inhibitor of F-actin (Latrunculin A). These new results support our original hypothesis that the EMS and P2 cells are protected against cytokinesis failure when the actin cytoskeleton is weakened, and they are now included in this revised manuscript. For more details, please see also our responses to individual reviewer comments about both points below.

> 3\) The strength of evidence on whether other formins are dispensable for cytokinesis in the 4 cell embryo (all reviewers).

To address this point, we have now added references about the expression of other formin-related genes and adapted the text as suggested by the reviewers. The diaphanous formin^CYK-1^ is the only formin shown to have a role in assembling contractile ring F-actin during cytokinesis in *C. elegans*. However, there are two other formin-related proteins expressed in 4-cell stage embryos: FRL-1 and INFT-2 (Hashimshony et al., 2015). Single cell RNAseq data from individual blastomeres of the 4-cell embryo revealed that none of the worm formin-related genes, including *cyk-1,* are significantly enriched in either EMS or P2, compared to in ABa or ABp cells (Tintori et al., 2016). Our mini-RNAi screen for additional formin-related proteins that might compensate for loss of formin^CYK-1^ activity was done at restrictive temperature (26ºC) in the *formin^cyk-1^(ts)* mutant background. We expected, that if another formin was functioning redundantly with formin^CYK-1^, then depletion of that formin would increase the rate of cytokinesis failure in EMS and/or P2. We did not find this to be the case, as depletion of the six *C. elegans* formin-family members did not increase the frequency of cytokinesis failure in any of the cells within the 4-cell embryo in *formin^cyk-1^(ts)* mutants. However, we agree that we cannot rule out insufficient protein depletion or that multiple formin-related proteins may work together to promote cytokinesis in these cells when formin^CYK-1^ activity is reduced and we now state this clearly in the manuscript text.

> 4\) Links between polarity proteins and cell type specific cytokinesis (raised by 2 and 3).

We agree that cell polarity could be affecting cytokinesis in a cell type specific manner during asymmetric cell division. Both of the robustly dividing cells, EMS and P2 divide asymmetrically (Arata et al., 2010; Heppert et al., 2018), and in previous work we found that PAR proteins aid robust cytokinesis in the 1-cell embryo (Jordan et al., 2016). However, the exact mechanisms of polarity establishment and/or maintenance in EMS and P2 are not as well studied as in the 1-cell *C. elegans* embryo. The PAR proteins localize to opposing cortical domains in P2, but are not as obviously asymmetrically distributed in EMS (Arata et al., 2010). Cell polarity in these later divisions is difficult to study due to the lack of conditional tools that disrupt the cell polarity proteins specifically in 4-cell embryos, while allowing normal cell polarity establishment and maintenance in asymmetrically dividing 1- and 2-cell embryonic parental cells (*i.e.* fast-acting ts PAR mutants). Thus, to address this reviewer comment, we have now added data showing *par-6(RNAi)* eliminates the cell-type specific protection of EMS and P2 against cytokinesis failure in *formin^cyk-1^(ts)* mutant 4-cell embryos at restrictive temperature (Figure 8---figure supplement 1). We also note that in *par-6(RNAi)* treated embryos at the 4-cell stage, cell fate specification and lineage patterning have been massively disrupted due to the loss of polarity in the asymmetric 1- and 2-cell divisions.

> 5\) Links between Wnt/Src and cell type specific cytokinesis (reviewers 1 and 2).

We have now examined cytokinesis in *formin^cyk-1^(ts)* mutant embryos at 26ºC following *control(RNAi)* or *Src^src-1^(RNAi)*. We found that cytokinesis in EMS is dependent on Src^SRC-1^ signaling, whereas cytokinesis in P2 is Src^SRC-1^ independent. These results are now included in the revised manuscript (Figure 8).

> Reviewer \#1:
>
> The process of physical separation of two cells, Cytokinesis, is regulated by numerous cell autonomous and non-autonomous cues. While constriction of an equatorial actomyosin network powers plasma membrane closure, the ability to regulate its spatiotemporally varies among cell types. In this work the authors present a thorough illustration of this principle in 4 cell stage of C.elegans. Using fast acting temperature sensitive alleles the authors show that cell fate influences the ability of a cell type to withstand Formin and actin perturbation. This is regulated both in a cell intrinsic and extrinsic fashion requiring neighbouring cell contacts.
>
> The methodology and presentation of data is undoubtedly impressive. However, several conclusions appear to be an over-estimates the data. The text is well written yet offers little information on the process of cytokinesis and focuses almost exclusively on its outcome and failure. The authors on several occasions make categorical statements that at least to me appear inconclusive.

We thank reviewer 1 for their constructive criticisms and we are pleased that they found the data and methodology in our original submission impressive. We have now added substantial new data and made changes to the text and figures based on their suggestions, and we are hopeful this reviewer will now find the manuscript suitable for publication.

> Major Points:
>
> 1\) Figure 3---figure supplement 1
>
> \"This suggests that another formin-related protein is not compensating for loss of formin CYK-1 activity\"
>
> I concur that none of the formins at least individually show a strong synthetic defect with CYK-1ts. However that doesn\'t rule out the possibility that formins may act synergistically. Therefore, the conclusive statement doesn\'t stand merit.

We agree, and we have adjusted the text accordingly. It is true that our RNAi mini-screen results cannot exclude the possibility that multiple formin-related proteins function synergistically during cytokinesis in the absence of formin^CYK-1^ activity. The diaphanous formin^CYK-1^ is the only formin known to have a role in contractile ring F-actin assembly in *C. elegans*, and only two other formin-related proteins are expressed in the 4-cell embryo (*frl-1* and *inft-2;* (Hashimshony et al., 2015)), which could act redundantly when formin^CYK-1^ activity is reduced in EMS and/or P2 cells. Single cell RNAseq data of individual blastomeres of the 4-cell embryo indicates that no other formin-related protein is significantly enriched in either EMS or P2 compared with either the ABa or ABp cells (Tintori et al., 2016). Because we do not see a robust F-actin contractile ring during cytokinesis in EMS and P2 cells in *formin^cyk-1^(ts)* mutant embryos at restrictive temperature using fluorescently-tagged F-actin reporters, we argue it is unlikely another formin 'takes over' to promote the assembly of contractile ring F-actin when formin^CYK-1^ activity is reduced. Additionally, we have now perturbed actin polymerization independent of formin-disruption, by treating control, non-ts mutant, embryos treated with the pharmacological inhibitor of F-actin assembly, LatrunculinA (LatA). We found that, similar to what is observed in the *formin^cyk-1^(ts)* mutant, ABa and ABp blastomeres consistently failed at cytokinesis when treated with low doses of LatA (50, 67, or 80 nM), whereas the EMS and P2 blastomeres successfully completed cytokinesis at a high frequency at the same LatA concentrations. Both of these results suggest that a simple model of cell-specific redundancy between different formin family members is not the likely mechanism of robust cytokinesis in EMS and P2 cells in *formin^cyk-1^(ts)* mutant embryos. Nevertheless, we have added this possibility to this section of the Results.

> 2\) \"This suggests that EMS-P2 cell-cell contact mediates cell-extrinsic cues that protect against cytokinesis failure due to forminCYK-1 disruption in EMS\".
>
> The set of observations leading to this particular conclusion involves examining EMS-P2 pair after CYK-1 inactivation. Currently, it is not possible therefore to distinguish between the specific requirements of P2 versus requirement of an unspecified neighbouring cell. Whether the ABp-EMS pair would behave similarly can not be hypothesised. Therefore the conclusion, I believe, is the presence of a neighbouring cell. Unless the authors prove or show specific mechanisms originating from P2, the current conclusion seems a stretch.

This is a great point and we have now taken both approaches suggested by the reviewer, and now include this critical control in the revised manuscript. We first assessed the frequency of cytokinesis success in isolated EMS blastomeres paired with ABd blastomeres from *formin^cyk-1^(ts)* mutants. In this experiment, \~50% of the time the cells are paired with ABa and \~50% of the time they are paired with ABp (after isolation, we term these cells 'ABd' for AB-daughter cells because they cannot be distinguished). We found that, similar to isolated (unpaired) blastomeres, EMS cannot undergo cytokinesis when in direct contact with ABd blastomeres. This suggests that a P2-specific signal is required to protect against cytokinesis failure in EMS when the contractile ring is weakened. These new data are included in the revised manuscript (Figure 7C).

To further address this reviewer concern, we also tested more directly if Src/Wnt cell fate signaling from P2 mediates protection against cytokinesis failure in EMS after depleting Src^SRC-1^ by RNAi. We found that following RNAi-mediated depletion of Src^SRC-1,^protection of EMS cytokinesis in intact 4-cell embryos from *formin^cyk-1^(ts)* mutants is lost, despite intact cell-cell contacts with the ABa, ABp and P2 cells. This result supports a model in which cytokinesis in EMS is dependent on activation of Src^SRC-1^ in EMS by direct contact with P2, as occurs during cell fate specification (Bei et al., 2002). These new data are included in the revised manuscript (Figure 8D).

> 3\) The Cell-extrinsic vs intrinsic angle indeed adds a dimension to this work. One would be curious to know, particularly in the EMS, whether the myosin-II ts yields an expected phenotype.

We respectfully disagree that this experiment will substantially add to the manuscript, as we do not have evidence of cell-type specific myosin-II^NMY-2^ regulation during cytokinesis at the 4-cell stage. We found that in *myosin-II^nmy-2^(ts)* mutant embryos, all 4 blastomeres fail in cytokinesis equally at restrictive temperature (100% of the time). We expect upon isolation all 4 blastomeres would also fail in cytokinesis 100% of the time. While it is hypothetically possible that some cell-extrinsic pathway affects cytokinesis when myosin-II^NMY-2^ activity is reduced, we do not have any evidence to support a cell extrinsic pathway contributing to cytokinesis failure in a *myosin-II^nmy-2^(ts)* mutant. In the *formin^cyk-1^(ts)* mutant, we had in vivo evidence that there was a difference between cytokinesis in the cells in intact embryos versus in isolated blastomeres, as EMS and P2 were able to divide when formin^CYK-1^ activity was reduced in intact embryos, but only P2 could divide upon isolation. We do not have this evidence in *myosin-II^nmy-2^(ts)* mutants. Embryo microdissection and blastomere isolation experiments are laborious and not suited to exploratory work, unless a direct hypothesis is being tested. Thus, in our opinion this experiment is out of the realm of reasonable experimental requests.

> 4\) Figure 5.
>
> I am unable to follow the logic here clearly. The spindle morphology has a direct impact on cytokinesis (beyond its spatial positioning). Spindles are therefore a cause of any cytokinesis defect under study. Proper spindle alignment (Figure 5E), does not guarantee successful cytokinesis. In CYK-1 ts, the distribution is visibly wider with some cases of proper spindle alignment and yet cytokinesis fails. I agree cases of successful cytokinesis seems to be correlative to proper spindle alignment. But this as a whole is incomplete and inconclusive. The authors do not make an attempt to conclude this section and one fails to see what exactly the authors allude to here.

We apologize for not stating the relationship between spindle angle and cell fate specification clearer in our original submission, or for in any way implying there an effect on overall spindle morphology. The spindle angle we measured is the angle of the EMS spindle relative to the P2-EMS cell-cell contact axis, not the spindle angle relative to the division plane (which are still perpendicular to each other, as occurs normally). To be clear, the axis of the cell division plane (and site of equatorial constriction) during cytokinesis is always perpendicular to the spindle angle in all EMS and P2 cells from control or *formin^cyk-1^(ts)* embryos in both intact and isolated blastomeres, as it is typically in animal cells undergoing cytokinesis. Thus, we do not believe mis-positioning the spindle angle relative to the division plane is affecting cytokinesis directly in this context and we do not see gross effect of formin^CYK-1^ disruption on spindle morphology.

The EMS spindle angle has been previously published as a read-out for correct P2 to EMS cell fate signaling in the *C. elegans* 4-cell embryo, and was the assay used to show that Wnt^MOM-2^ and Src^SRC-1^ signals act in parallel and non-redundantly for cell fate specification in EMS to promote cell division asymmetry and gut induction (Bei et al., 2002; Liu et al., 2010). However, we understand this is confusing and complicated. We have therefore significantly restructured this section to make the text clearer. We have now also added analysis showing that cytokinesis in EMS (within an intact embryo) is dependent on Src^SRC-1^ signaling, thus greatly improving the strength of our argument that cell fate signaling, which results in EMS spindle angle orientation, promotes robust cytokinesis in this blastomere.

It is also important to state that at this point of our studies we do not fully understand how P2contact dependent Src^SRC-1^ activation leads to protection against cytokinesis failure in EMS when the F-actin cytoskeleton is weakened with either the *formin^cyk-1^(ts)* mutant or with low doses of LatA. Thus, it is entirely possible that spindle signaling contributes to this cell type specific protection in EMS and/or P2. In light of this, we have now added this possibility to the discussion.

> Reviewer \#2:
>
> This manuscript reports the cell-type dependent phenotypes of a temperature-sensitive allele of cyk-1 formin in 4-cell stage C. elegans embryos. Inactivation of this f-actin nucleator during the first cell division by temperature upshift results in highly penetrant cytokinesis failure. Interestingly, while division of ABa and ABp cells was strongly inhibited by a similar temperature upshift during 4 cell stage, P2 and EMS divisions were more resistant and even at 26°C (the highest temperature that allows robust cell divisions in the wild type embryos) about 30-50% of these divisions completed successfully. Further, by blastomere isolation and recombination experiments, the authors revealed that cytokinesis of the EMS cell with reduced CYK-1 activity depends on the cell-cell contact between the EMS and P2 cells while the P2 division is independent of the contact with other cells. Based on these observations, the authors conclude that both the cell-intrinsic and extrinsic mechanisms protect against division failure due to defective contractile ring.
>
> Establishment of an experimental system that allows further study of cell-type dependent variation in the mechanism of cytokinesis is a highly valuable achievement. However, there are major shortfalls in the current manuscript as below.

We are pleased reviewer 2 found our establishment of the 4-cell *C. elegans* embryo for the study of cell-type variation in cytokinesis a valuable achievement. We also appreciate their helpful comments on our manuscript, especially their detailed reading of the Materials and methods and notice of several key errors. We hope that we have fully addressed their concerns.

> 1\) The authors implicitly assume that 1) the temperature sensitivity of cytokinesis failure is derived of the temperature sensitive inactivation of CYK-1 (ts) mutant protein and 2) the levels of residual CYK-1 activity after temperature upshit are invariable across the four different cell types (or completely inactivated in all the four cells). However, neither of these assumptions have been confirmed.
>
> In Davies (2014), they compared CYK-1 FH1FH2C fragments with and without the L1015H mutation found in the cyk-1(ts) allele and showed that this mutation inactivates the in vitro actin polymerizing activity at 25°C. However, it remained unclear whether the CYK-1 mutant is active at 15°C or not (this actually should have been examined at the publication of the 2014 paper). Thus, currently, we can\'t exclude the possibility that the CYK-1 L1015H mutant protein is inactive at 15°C as well, and the mutant cell can complete cytokinesis at 15°C, but not at higher temperature, because of the presence of an unknown redundant pathway whose activity is intrinsically temperature-sensitive. If this was the case, the cell-type dependent ts phenotypes would not be reflecting the variable responses to the defective actin polymerisation but be indicating the variable activities of this redundant pathway.
>
> Even if the temperature-sensitive cytokinesis failure of cyk-1(ts) was caused by the temperature-sensitive activity of the mutant protein, currently, there is no direct evidence that the cellular CYK-1 activity is inactivated uniformly across the four cell types. The cell type specificity might be caused by the variable level of the residual activity of CYK-1. If so, observed data should be interpreted as indicating the variations in a cellular mechanism for the expression of the CYK-1 activity, rather than the plasticity against the defective contractile ring.

We agree that we did make these two assumptions in our initial manuscript. As discussed in our response to the reviewer and editorial comments above, we have now confirmed that the L1015H mutation in cyk-1(ts) causes loss of F-actin accumulation at the contractile ring, in a temperature-dependent manner. We initially tested this at the 1-cell stage to test the effect of temperature on *formin^cyk-1^(ts)* mutants for two main reasons: 1) the F-actin reporters are brighter and easier to image due to the absence of cell-cell contacts at the 1-cell stage; and 2) the essential role of formin^CYK-1^ at the 1-cell stage has been studied using non-ts mutations (Severson et al., 2002) and RNAi (Sonnichsen et al., 2005; Swan et al., 1998). These data are now included in the revised manuscript (Figure 1---figure supplement 1). We also measured contractile ring levels at the 4-cell stage in ABa, ABp, EMS, and P2 (Figure 4, and Figure 4---figure supplement 1-3).

We measured the levels of F-actin in the contractile ring at both permissive and restrictive temperatures (16ºC and 26ºC) in control and *formin^cyk-1^(ts)* mutant embryos using multiple fluorescently-tagged F-actin reporters (Lifeact::RFP, GFP::PLST-1, or GFP::Utrophin^ABD^). We found that contractile ring F-actin levels were lower in *formin^cyk-1^(ts)* mutant embryos than in control embryos at 16ºC (permissive temperature), and contractile ring F-actin levels were undetectable in *formin^cyk-1^(ts)* mutant embryos at 26ºC (restrictive temperature). This suggests the *formin^cyk-1^(ts)* mutant is indeed temperature sensitive for formin^CYK-1^-mediated F-actin polymerization at 26ºC and, despite providing sufficient formin^CYK-1^ activity to support organismal viability and germline function (Jordan et al., 2016), is not fully wildtype at 16ºC.

Thus, to address this reviewer concern in a different way, we also targeted F-actin polymerization independent of formin^CYK-1^ activity by treating embryos with a pharmaceutical inhibitor of F-actin (LatrunculinA or LatA). We found that, similar to what is observed in the *formin^cyk-1^(ts)* mutant, ABa and ABp blastomeres consistently failed at cytokinesis when treated with low doses of LatA (50, 67, or 80 nM), whereas the EMS and P2 blastomeres successfully completed cytokinesis at a high frequency at the same LatA concentrations. These new results support our original hypothesis that the EMS and P2 cells are protected against cytokinesis failure when the actin cytoskeleton is weakened, and they are now included in this revised manuscript (Figure 3).

> 2\) The manuscript is rather descriptive and misses clear insight into the molecular mechanisms. In Jordan (2016), the authors reported the synthetic effects between the cyk-1(ts) and depletion of PAR proteins. Are the expression levels/cortical localization of the PAR proteins in the 4 cell types consistent with the cell type dependent phenotypes in cyk-1(ts) embryos? Does inactivation of the WNT or SRC signalling affect cytokinesis of the cyk-1(ts) mutant EMS cell?

To address this concern, we directly tested if Src/Wnt cell fate signaling from P2 mediates protection against cytokinesis failure in EMS by RNAi-inhibition of Src^SRC-1^. We found that following RNAi-mediated depletion of Src^SRC-1,^protection of EMS cytokinesis in intact 4-cell embryos from *formin^cyk-1^(ts)* mutants is lost, despite intact cell-cell contacts with the ABa, ABp and P2 cells. This result supports a model in which cytokinesis in EMS is dependent on activation of Src^SRC-1^ in EMS by direct contact with P2, as occurs during cell fate specification (Bei et al., 2002). These new data are included in the revised manuscript (Figure 8D).

We agree that cell polarity could be affecting cytokinesis in a cell type specific manner during asymmetric cell division. Both of the robustly dividing cells, EMS and P2, divide asymmetrically (Arata et al., 2010; Heppert et al., 2018), and in previous work we found that PAR polarity proteins aid robust cytokinesis in the 1-cell embryo (Jordan et al., 2016). However, the exact mechanisms of polarity establishment and/or maintenance in EMS and P2 are not as well studied as in the 1-cell *C. elegans* embryo. The PAR proteins localize to opposing cortical domains in P2, but are not as obviously asymmetrically distributed in EMS (Arata et al., 2010). Cell polarity in these later divisions is difficult to study due to the lack of conditional tools that disrupt the cell polarity proteins specifically in 4-cell embryos, while allowing normal cell polarity establishment and maintenance in asymmetrically dividing 1- and 2-cell embryonic parental cells (*i.e.* fast-acting ts PAR mutants). To address this reviewer comment, we have now added data showing *par-6(RNAi)* eliminates the cell-type specific protection of EMS and P2 against cytokinesis failure in *formin^cyk-1^(ts)* mutant 4-cell embryos at restrictive temperature (Figure 8---figure supplement 2). We also note that in *par-6(RNAi)* treated embryos at the 4-cell stage, cell fate specification and lineage patterning have been massively disrupted due to the loss of polarity in the asymmetric 1- and 2-cell divisions.

> 3\) Data about the f-actin levels in the cleavage furrow (Figure 3) are not convincing. About 50\~70% of the cyk-1(ts) mutant EMS and P2 cells fail cytokinesis while 30\~50% complete it. The successful cells might have more robust contractile ring than the unsuccessful ones. Successful cells and failed cells should be analyzed separately as the author did in Figure 5---figure supplement 1.

We have now quantified contractile ring F-actin levels relative to the outcome of cytokinesis in *formin^cyk-1^(ts)* mutant strains expressing the RFP::Lifeact and PLST-1::GFP F-actin reporters. We compared contractile ring F-actin levels in EMS and P2 cells that divide successfully versus in those that fail to divide. Despite this effort, we have found no detectable levels of F-actin in the contractile ring in *formin^cyk-1^(ts)* mutant EMS or P2 blastomeres that succeed or fail to divide. Although we cannot detect it, it is possible that the successful cells have more robust contractile rings than the unsuccessful cells. However, even if this were true, this does not negate our results: EMS and P2 blastomeres are more successful at cytokinesis in the absence of formin^CYK-1^ activity or in the presence of LatA than the 1-cell embryo or ABa/ABp cells; this cytokinetic protection is intrinsically regulated for P2 cells and extrinsically regulated for EMS cells; and extrinsic regulation in EMS cells is dependent on Src^SRC-1^ signaling from P2 cells.

As we stated previously, all of these F-actin reporter strains are very dim and thus 1) are difficult to image and 2) an undetectable signal is difficult to interpret. We do not and cannot state that there is no F-actin in the contractile ring in these successfully dividing *formin^cyk-1^(ts)* mutant blastomeres, just that we cannot detect differences in F-actin levels between successful and unsuccessful EMS and P2 cells. The reason we present the contractile ring F-actin levels in *formin^cyk-1^(ts)* mutants is to demonstrate there is not a major redundant F-actin nucleating factor and/or massive F-actin stabilization in the EMS or P2 cells specifically, which could explain the ability of these two cells to divide in the absence of formin^CYK-1^ activity. We have made an effort to revise the text to ensure that we do not over-state this result.

> Reviewer \#3:
>
> The mechanisms of cytokinesis remain elusive despite decades of work. The lack of resolution of a universal mechanism may stem in part from the employment of a wide range of model cell types. It is unclear whether reported differences reflect cell-type specific distinctions or a general absence of redundant mechanisms in some systems. Davies and colleagues compared the molecular requirements for cytokinesis of several cells in the early C. elegans embryo. They combined the well-characterized fate specification of the cells with powerful, time-resolved perturbations of major conserved cytokinesis proteins via temperature sensitive mutant alleles. The manuscript is a technical tour-de-force, with exquisite cell manipulation experiments in addition to temperature shift work with intact embryos. It is exceptionally comprehensively referenced, and will set a new standard for the field. That said, since the authors are not able to resolve the problem of how certain cells divide following strong reduction of F-actin by CYK-1 (ts) upshift, I recommend a finite list of things to try and to consider. I feel confident that after these concerns are addressed, this manuscript will be suitable for publication in eLife.

We are pleased reviewer 3 found the data and methodology in our original submission impressive and thank them for their critical comments. We have now added new data and made substantial changes to the text based on their suggestions, and we are hopeful this reviewer will now find the manuscript suitable for publication.

> Major Points:
>
> 1a) F-actin levels and distribution need to be quantified and presented for the AB lineage, comparing control and formin ts shifted embryos.

We measured the levels of F-actin in the contractile ring in ABa and ABp at both permissive and restrictive temperatures (16ºC and 26ºC) in control and *formin^cyk-1^(ts)* mutant embryos expressing Lifeact::RFP, the brightest of the F-actin reporters at the 4-cell stage on our microscope system. We found that contractile ring F-actin levels were lower in *formin^cyk-1^(ts)* mutant embryos than in control embryos at 16ºC (permissive temperature) and contractile ring F-actin levels were undetectable in ABa and ABp (like in EMS and P2) in *formin^cyk-1^(ts)* mutant embryos at 26ºC (restrictive temperature). These results show that the *formin^cyk-1^(ts)* mutant is indeed temperature sensitive for formin^CYK-1^-mediated F-actin polymerization at 26ºC and, though not fully wildtype at 16ºC, provides sufficient formin^CYK-1^ activity to support actin polymerization, organismal viability, and germline function (Jordan et al., 2016).

> 1b) The lack of an effect of targeting other formins is not fully satisfying, since no positive control is provided to ensure that they are depleted. One potential way to augment the exploration of these other formins is to consult a recent comparative transcriptomics study that may be able to verify which formins are expressed in the various early blastomeres (Tintori et al., Dev. Cell. 2016).

We have now added information (and references) about the expression of other formin-related genes in 4-cell *C. elegans* embryos as suggested. The diaphanous formin^CYK-1^ is the only formin shown to have a role in assembling contractile ring F-actin during cytokinesis in *C. elegans*. However, there are two other formin-related proteins expressed in 4-cell stage embryos: FRL-1 and INFT-2 (Hashimshony et al., 2015). Single cell RNAseq data from individual blastomeres of the 4-cell embryo revealed that none of the worm formin-related genes, including *cyk-1,* are significantly enriched in either EMS or P2, compared to ABa or ABp cells (Tintori et al., 2016). Our mini-RNAi screen for additional formin-related proteins that might compensate for loss of formin^CYK-1^ activity was done at restrictive temperature (26ºC) in the *formin^cyk-1^(ts)* mutant background. We expected that if another formin was functioning redundantly with formin^CYK-1^, then depletion of that formin would increase the rate of cytokinesis failure in EMS and/or P2. We did not find this to be the case, as depletion of the six *C. elegans* formin-family members did not increase the frequency of cytokinesis failure in any of the cells within the 4-cell embryo in *formin^cyk-1^(ts)* mutants. However, we cannot rule out insufficient protein depletion or that multiple formin-related proteins may work together to promote cytokinesis in these cells when formin^CYK-1^ activity is reduced and we now state this clearly in the manuscript text.

To address this reviewer's concern in a different way, we also targeted F-actin polymerization independent of formin^CYK-1^ activity by treating embryos with a pharmaceutical inhibitor of F-actin (LatrunculinA or LatA). We found that, similar to what is observed in the *formin^cyk-1^(ts)* mutant, ABa and ABp blastomeres consistently failed at cytokinesis when treated with low doses of LatA (50, 67, or 80 nM), whereas the EMS and P2 blastomeres successfully completed cytokinesis at a high frequency at the same LatA concentrations. These new results support our original hypothesis that the EMS and P2 cells are protected against cytokinesis failure when the actin cytoskeleton is weakened, and they are now included in this revised manuscript (Figure 3).

> 1c) Have the authors verified their analysis of F-actin levels using a second, distinct F-actin probe (LifeAct or the ABD of moesin)? It seems possible that these probes detect slightly different sub-populations of F-actin. I do not expect the authors to introduce fluorescently-labeled phalloidin or recombinant G-actin into embryos to distinguish different F-actin pools as has been done (see for example Burkel, von Dassow and Bement, Cytoskeleton 2007). The authors could label a non-formin-nucleated pool with a GFP-actin (Chai, Ou and colleagues, Nature Protocols, 2012).

We have now quantified contractile ring F-actin levels in the *formin^cyk-1^(ts)* mutant in strains expressing the F-actin reporters RFP::Lifeact, PLST::GFP, and GFP::Utrophin^ABD^. Using RFP::Lifeact, the brightest of the strains at the 4-cell stage on our microscope, as well as PLST::GFP, we also correlated the levels of F-actin in the contractile in ring in EMS and P2 cells that fail versus complete cytokinesis. Despite this effort, we found no detectable levels of F-actin in the contractile ring in either cells that complete or cells that fail to divide successfully. Although there is evidence to suggest different F-actin reporters label different sub-populations of F-actin (Belin et al., 2014; Bement et al., 2015), both of these markers are able to label the contractile ring in the 1-cell stage *C. elegans* embryo (Figure 1---figure supplement 1, RFP::Lifeact and PLST::GFP; Figure 4---figure supplement 3, eGFP::Utrophin^ABD^).

> 1d) The authors should examine the localization of fluorescently-tagged CYK-1 during cytokinesis of the 4 cells they study.

To address this concern, we used a CRISPR/Cas9 approach (Dickinson and Goldstein, 2016) to generate a fluorescently tagged formin^CYK-1^ (CYK-1::eGFP). We found that CYK1::eGFP localized nearly exclusively to the contractile ring in all 4 blastomeres, and contractile ring levels of CYK-1::eGFP in each cell did not significantly differ between the 4 cells. This is in agreement with single blastomere RNAseq analysis which showed no significant differences in *cyk-1* mRNA between the blastomeres (Swan et al., 1998; Tintori et al., 2016). These results are now included in Figure 5.

> 2\) In cases where cytokinesis is more successful than expected (insensitive cells), is initiation late? I.e. is overall duration longer than expected?

To investigate this, we measured the rate of ingression in EMS and P2 cells in control and *formin^cyk-1^(ts)* mutant embryos at 26ºC and include this analysis in Figure 2---figure supplement 1. We observed that EMS and P2 cells in control embryos initiated and completed contractile ring constriction more quickly than in *formin^cyk-1^(ts)* mutant embryos, even when we limited our comparison to cells that divide successfully. When comparing the initiation time and initial rate of ingression, there was no clear difference between those that complete or those fail in cytokinesis. However, this analysis is obscured in cells that only weakly ingress due to the variable phenotype and by cell shape changes due to the movement and division of neighboring cells in the embryo. Due to the lack of ingression in ABa and ABp cells, we were unable to compare the initiation or ingression timing between the 4 cell types upon Formin^CYK-1^ inhibition.

> 3\) It would seem not outside the scope of this paper to combine the cyk-1 ts and a par mutant and shift the P2 after dissociation, to determine the role of polarity in protecting the P2.

We agree that PAR-protein dependent cell polarity could be affecting cytokinesis in the P2 cells and were very keen to perform the experiment suggested by the reviewer (both in vivoand isolated P2 cells in vitro). Both of the robustly dividing cells, EMS and P2, divide asymmetrically (Arata et al., 2010; Heppert et al., 2018), and in previous work we found that PAR polarity proteins aid robust cytokinesis in the 1-cell embryo (Jordan et al., 2016). However, the exact mechanisms of polarity establishment and/or maintenance in EMS and P2 are not as well studied as in the 1-cell *C. elegans* embryo. The PAR proteins localize to opposing cortical domains in P2, but are not as obviously asymmetrically distributed in EMS (Arata et al., 2010). Cell polarity in these later divisions is difficult to study due to the lack of conditional tools that disrupt the cell polarity proteins specifically in 4-cell embryos, while allowing normal cell polarity establishment and maintenance in asymmetrically dividing 1- and 2-cell embryonic parental cells (*i.e.* fast-acting ts PAR mutants). Unfortunately, none of the \~5 available ts PAR alleles (Fievet et al., 2013) are "fast acting" (able to disrupt cell division asymmetry in the 1-cell embryo upon upshift \<10-15 min before NEBD), and only one allele (*pkc-3(ne4250ts)*) disrupted cell polarity in the 1-cell embryo when upshifted \>20 minutes before cell division, at least in our hands. Importantly, this one ts allele did not disrupt division asymmetry in 2- and 4-cell embryos (including in either EMS or P2). Thus, to address this reviewer comment, we have now added data showing *par-6(RNAi)* eliminates the cell-type specific protection of EMS and P2 against cytokinesis failure in *formin^cyk-1^(ts)* mutant 4-cell embryos at restrictive temperature (Figure 8---figure supplement 1). We also note that in *par-6(RNAi)* treated embryos at the 4-cell stage, cell fate specification and lineage patterning have been massively disrupted due to the loss of polarity in the asymmetric 1- and 2-cell divisions.

> 4\) Can the authors explain why higher temperatures do not always produce more severe phenotypic classification (i.e. Figure 1C, AB lineage, myosin and cyk-1 ts)? Is there compensation for the loss of function by an increase in things jiggling around? Similarly, why is shifting earlier not always worse (i.e. Figure 2B, EMS and P2, formin mutant)? Are un-scored embryos dying and scored, live ones less severely affected somehow?

We agree that there are some intermediate temperatures and temporal upshifts where a higher temperature, or longer upshift, causes a weaker phenotype than a slightly higher temperature or longer upshift. We think this is unlikely to be due to cell death, as at these temperatures we don't observe cell death in a temperature-dependent manner (we never see cells die upon upshift). We consistently follow cell division until the daughter cells begin to divide again, to ensure the cells are still cycling. Although cells in control embryos divide in a highly stereotypical manner, perturbation (*e.g.* by RNAi or with ts mutants) adds some variability cell biology in this system, and this variability seems to be increased at intermediate temperatures. Furthermore, the number of cells analyzed varied between the different temperatures and upshift times; thus a few blastomeres that fail or succeed in cytokinesis at a given temperature could have large effects depending on the size of the data set. To improve clarity, we have now added the n's directly to all panels in Figures 1 and 2, with a further breakdown in the supplemental data file (Supplementary file 1).

\[Editors\' note: the author responses to the re-review follow.\]

> In the discussion between reviewers, point 5 was emphasised as being important by ALL three reviewers.
>
> 1\) Unfortunately, our suggestion of repeating an in vitro experiment to check the actin polymerization-promoting activity of the mutant version of CYK-1 at 16°C was neglected (or not presented). However, the authors measured the levels of F-actin in the contractile ring in the mutant embryos. Since the readout of this assay is the influence of the formin mutation on the complex cellular process of F-actin polymerization, it can also address our question though only indirectly. Anyway, irrespective of cell types and probes, the furrow F-actin levels in cyk-1(ts) mutant embryos at 16 °C were lower than those in wildtype embryos at 16 °C (Figure 4E, Figure 4---figure supplement 1C and Figure 4---figure supplement 3B). This suggests that CYK-1 L1015H mutant protein is not fully functional as the wildtype protein, as the authors admitted in the letter of rebuttal. However, although I am afraid that I might have just overlooked, I could not find any mention about this fact, which is important for the readers to understand the technical and conceptual limitation of the authors\' approach, in the main text.

We apologize for not addressing this request to conduct pyrene actin assays with the CYK1(ts) mutant at 16ºC and 26ºC in our previous Resubmission; we did not understand that the reviewers were asking for this specifically. We understood that the reviewers were asking if the CYK-1(ts) mutant protein is fully functional for F-actin polymerization at permissive temperature, and we addressed this in vivoin our previous Resubmission. Unfortunately, it is simply not possible to do comparative in vitro activity studies at different temperatures with most biochemically purified ts mutant proteins. Our understanding is that ts mutant proteins show high protein instability at all temperatures once the ts protein is removed from the stabilizing environment of the cell, which contains molecular and structural protein chaperones. When we first published on this ts mutant, we asked Dr. David Kovar (U. Chicago), our collaborator who did the original pyrene actin assay comparing the in vitroactivity of wildtype CYK-1 to CYK-1(ts) (L1015H) (Davies et al., 2014), to do the pyrene actin assay at a low permissive temperature, despite the unlikeliness it would work. However, the Kovar lab did not have access to a cooling plate reader required for the assay and told us these are expensive and not commonly used. In any case, we agree with the reviewer: our in vivo data in this manuscript and in our previous publications on the *cyk-1(ts)* mutant, clearly show that the *cyk1(or596ts)* allele is not fully functional at permissive temperature. Importantly, though, CYK1(ts) mutant protein is functional enough at permissive temperature to support cell division, organismal development, and fertility. Moreover, when we examine the cytokinesis of single cells in *cyk-1(ts)* mutant embryos, cytokinesis is always successful at the permissive temperature in every cell-type we've analysed to date. These data were included in our previous submission and now this point is explicitly stated in the Results section of the main text:

"In *formin^cyk-1^(ts)* mutant 1-cell *C. elegans* embryos at 16ºC, F-actin is present in the contractile ring (although at lower levels than in control embryos), but upon upshift to 26ºC linear F-actin is no longer visible and cytokinesis fails (Figure 1---figure supplement 1 and Davies et al, 2014)."

> In the rebuttal, the authors wrote, \"we have now measured the levels of F-actin in the contractile ring at both permissive and restrictive temperatures (16°C and 26°C) in control and formin cyk-1(ts) mutant embryos\". However, I couldn\'t find any data for the ring F-actin levels in wildtype embryos at the restrictive temperature. Knowing now that CYK-4 ts mutant protein is not fully functional even at the permissive temperature, we can\'t exclude the possibility that the cytokinesis phenotype by acute temperature upshift might be triggered by acute inactivation of an unknown redundant mechanism for actin polymerization, which might be responsible for protecting the EMS and P2 cells from cytokines failure. In case of Figure 4E \'P2 cells\', for example, drop of F-actin levels in cyk-1(ts) embryos from \~3 to \~0 by temperature upshift could be due to a) further inactivation of the mutant CYK-1 protein or b) inactivation of an unknown factor that contributes to the ring actin polymerisation. Data about F-actin levels in the wildtype embryos will be helpful for discriminating these possibilities. If the temperature upshift didn\'t affect the F-actin levels in the wildtype embryos or promoted it, this would provide a strong support for scenario a). On the contrary, if the temperature upshift drops the F-actin levels in the wildtype embryos from \~6 (16°C) to \~3 (26°C) or lower, it would be reasonable to conclude that the scenario b) is more likely.

We now include data showing levels of contractile ring F-actin in control embryos at both 16ºC and 26ºC. We found the same levels of contractile ring f-actin in control embryos at both temperatures. As the reviewers suggest above, these data therefore rule out hypothesis (b) that an alternative temperature-sensitive mechanism promotes robust cytokinesis in the EMS and P2 cells. This result is also consistent with our acute LatA treatment results and suggests that cytokinesis in EMS and P2 is protected against failure when the contractile ring is weakened. These data can be found in the revised Figure 4 and Figure 4---figure supplement 3.

> 2\) I am afraid that I might be completely wrong, but I guess that the authors might already have the data of F-actin levels in wildtype embryos at 26°C since this is a very basic control. Whichever the results were, with the new data of the latrunculin A-sensitivity, the authors\' key discovery in the current manuscript that the EMS and P2 cells are protected against cytokinesis failure due to the perturbed actin cytoskeleton will not be affected. Depending on the results, the authors might need to revise their basic assumption that the temperature shift causes a phenotype by acutely inactivating the mutant protein with a \'fast-acting ts mutation\', on which they have been relying in previous publications. However, it is highly unnatural if the data of F-actin levels in wildtype embryos at 26°C is not shown. I strongly recommend showing the data of the F-actin levels in wildtype embryos at 26°C in at least one of Figure 4E, Figure 4---figure supplement 1C or Figure 4---figure supplement 3B (or Figure 1---figure supplement 1 although this is not really ideal), and properly discuss their implications on the possible mechanism for the acute induction of cytokinesis failure by temperature shift.

Please see our response to point 2 above. We now include data showing contractile ring F-actin levels in control embryos at both 16ºC and 26ºC. We found the same levels of contractile ring f-actin in control embryos at both temperatures. These results are now included in the revised Figure 4 and Figure 4---figure supplement 3.

> 3\) Figure 4---figure supplement 2C \'EMS\'
>
> A light blue half circle, probably derived from the markers of the graph points, is overlaid on a cartoon of a 6-cell stage embryo.

Thank you for noticing; this has now been corrected.

> 4\) Figure 3---figure supplement 1
>
> If we simply compare the control P2 cells (30 completion vs 40 failure, total n=70) with the inft-2(RNAi) (27 completion vs 14 failure, total n=41) by Fisher\'s exact test, the p-value will be 0.030. By Pearson\'s chi square test, it will be 0.032. This might be implying that inft-2, which is expressed at the 4-cell stage, might have an inhibitory role in the ring F-actin polymerization in the P2 cells although this is perfectly consistent with the authors\' statement \"we found that individual depletion of the other formin-related proteins did not decrease the frequency cytokinesis failure in any of the 4 blastomeres in formin cyk-1(ts) mutants.\" These simple calculations might not be appropriate for a complex dataset such as in Figure 3---figure supplement 1, to which care about multiple comparisons has to be paid, and the authors might have performed proper corrections, which might have made it \>0.05, the significance level used in other figures. More details about the statistical method for interpretation of this valuable dataset should be provided.

We appreciate the time that the reviewers took to carefully examine our results. The hypothesis we tested --does another formin act redundantly with CYK-1 in EMS and/or P2? -- is not supported by the data of this mini-screen. However, we agree that *inft-2(RNAi)* may have a partially suppressive effect on cytokinesis failure in *cyk-1(ts)* 4-cell embryos, and *inft-2* mRNA is reported to be expressed at the 4-cell stage (Tintori et al., 2016).

We analysed the cytokinesis outcome for each cell type, comparing between control and formin RNAi-treated embryos and testing for significance using Fisher's exact test. Other than P2 cells in *inft-2(RNAi)*-treated embryos (as the reviewers noted), no comparison yielded a p-value less than or equal to 0.05. We agree that, for this experiment, correcting for multiple comparisons is important to prevent false positives. To our knowledge, while there is no standardised way of correcting for multiple comparisons when using Fisher\'s exact or Pearson\'s chi square tests, Bonferroni correction is frequently used. In Bonferroni correction, a (the value against which the p-value is compared) is divided by the number of comparisons. In this experiment, we used 6 pairwise comparisons between the control RNAi and each formin gene RNAi within a given cell type in the 4-cell embryo. Therefore, the Bonferroni correction adjusted value of a is 0.050/6 or 0.0083. None of the calculated p-values is smaller than 0.0083, indicating that none of the RNAi treatments had a significant effect on cytokinesis outcome. See also Supplemental file 1.

To clarify this in the manuscript, we added the following text to the figure legend for Figure 3---figure supplement 1):

"In *formin^cyk-1^(ts)* embryos from each individual formin RNAi treatment, the cytokinesis outcome for each cell type was compared with the cytokinesis outcome from the same cell type in *formin^cyk-1^(ts)* embryos treated with *control(RNAi)*, using Fisher's exact text to examine the significance of any depletion. In all cases, the p-values were greater than 0.05, except for the P2 cell in *inft-2(RNAi); formin^cyk-1^(ts)* embryos which showed increased cytokinesis success with a p-value of 0.0299 relative to in *control(RNAi); formin^cyk-1^(ts)* embryos. However, using a Bonferroni correction to control for multiple comparisons adjusts α to 0.05/6 (or \~0.0083), suggesting that this result is not significant. See also Table S1."

> 5\) The intensity of both F-actin and formin is calculated in various panels of Figure 1 and Figure 3 using maximum intensity projection. In my opinion, they should use sum intensity projection.

We now include the sum intensity projection analysis in the revised Figure 1---figure supplement 1 for our analysis of F-actin levels in 1-cell *cyk-1(ts)* embryos at 16ºC and 26ºC. The results obtained with sum intensity projections were similar to those obtained with maximum intensity projections and are consistent with a temperature-sensitive F-actin polymerization defect in *cyk-1(ts)* embryos.

We also include the sum intensity analysis to Figure 3---figure supplement 1 in this Revision and similar to in Figure 1---figure supplement 1, the sum intensity analysis is consistent with the maximum intensity analysis and consistent with our overall hypothesis. However, we note here and in the text our concern with the sum intensity analysis for multi-cellular embryos. We include this analysis in response to the reviewers but would be happy to remove it if asked.

The main text now reads:

"Sum intensity projection analysis (total levels) revealed that formin^CYK-1^::eGFP is reduced in EMS and P2, versus ABa/ABp blastomeres (Figure 3---figure supplement 3). While the challenges of sum intensity projection analysis in multicellular embryos make it difficult to form conclusions about protein levels using this approach (see Materials and methods for additional information), these results are consistent with the maximum intensity projection analysis and do not support the hypothesis that resistance to formin^CYK-1^ inactivation in EMS and P2 is due to an endogenous enrichment of formin^CYK-1^ protein in these cells relative to ABa and ABp at the 4cell stage."

We argue that the maximum intensity projection is a better way to quantify fluorescence intensity differences at the contractile ring between individual blastomeres for four reasons. The multicellular 4-cell embryo is much more challenging to image and compare levels between individual cells than is the 1-cell *C. elegans* embryo because: 1) individual cells within the 4cell embryo vary in both their position within the 4-cell embryo and in their orientation during cell division (ABa and ABp divide perpendicular to the long embryo axis whereas EMS and P2 divide parallel to this axis); 2) there is rotational variation of individual embryos relative to the coverslip in every time lapse image series; 3) individual cells within the 4-cell embryo are of different volume and thus occupy different numbers of z-sections within the image stack, and 4) CYK-1::GFP is largely enriched at the cell cortex, but also occupies the cell cytoplasm. These issues impact sum projection analysis to a much greater extent than maximum projection analysis and in our opinion, render sum projection analysis unreliable for measuring the levels of CYK-1::GFP at the contractile ring in the 4-cell embryo. In our sum projection analysis of contractile ring CYK-1::GFP levels in the 4-cell embryo, for example, the contractile ring signal scales roughly with cell volume, with smaller cells showing reduced signal than the larger cells. Again, this result is still consistent with our hypothesis that CYK-1 protein is not expressed at higher levels in EMS or P2, but we are not confident that this result indicates a real difference in CYK-1 levels in individual cells within the 4-cell embryo. We are happy to remove this analysis and retain our note in the Materials and methods explaining why if the reviewers and/or Editors allow this.

The Materials and methods section describing our analysis of contractile ring formin^CYK-1^::eGFP levels in individual cells within the 4-cell *C. elegans* embryo now reads:

"In Figure 3, accumulation of formin^CYK-1^::eGFP was analyzed using a Z-series maximum intensity projection to select for the signal from the cortex next to the coverslip. \[...\] These issues impact sum projection analysis to a much greater extent than maximum projection analysis and in our opinion, render sum projection analysis less reliable for measuring the levels of formin^CYK-1^::eGFP (or other cortical proteins) at the contractile ring in the 4-cell embryo."
